514 Results of Phase 1b trial of the Indoleamine 2, 3-dioxygenase (IDO) Pathway Inhibitor Indoximod plus Ipilimumab for the treatment of unresectable stage III or IV melanoma (Englisch)
- Neue Suche nach: Zakharia, Y.
- Neue Suche nach: Drabick, J.
- Neue Suche nach: Khleif, S.
- Neue Suche nach: Munn, D.
- Neue Suche nach: Link, C.
- Neue Suche nach: Vahanian, N.
- Neue Suche nach: Kennedy, E.
- Neue Suche nach: Rixe, O.
- Neue Suche nach: Milhem, M.
- Neue Suche nach: Zakharia, Y.
- Neue Suche nach: Drabick, J.
- Neue Suche nach: Khleif, S.
- Neue Suche nach: Munn, D.
- Neue Suche nach: Link, C.
- Neue Suche nach: Vahanian, N.
- Neue Suche nach: Kennedy, E.
- Neue Suche nach: Rixe, O.
- Neue Suche nach: Milhem, M.
In:
European journal of cancer
;
51
;
S108
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:514 Results of Phase 1b trial of the Indoleamine 2, 3-dioxygenase (IDO) Pathway Inhibitor Indoximod plus Ipilimumab for the treatment of unresectable stage III or IV melanoma
-
Beteiligte:Zakharia, Y. ( Autor:in ) / Drabick, J. ( Autor:in ) / Khleif, S. ( Autor:in ) / Munn, D. ( Autor:in ) / Link, C. ( Autor:in ) / Vahanian, N. ( Autor:in ) / Kennedy, E. ( Autor:in ) / Rixe, O. ( Autor:in ) / Milhem, M. ( Autor:in )
-
Erschienen in:European journal of cancer ; 51 ; S108
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:S108
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 51
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Clinical relevance of the differential expression of the glycosyltransferase gene GCNT3 in colon cancerGonzalez-Vallinas, M. / Vargas, T. / Moreno-Rubio, J. / Molina, S. / Herranz, J. / Cejas, P. / Burgos, E. / Aguayo, C. / Custodio, A. et al. | 2015
- 9
-
High expression of the cysteine proteinase legumain in colorectal cancer - Implications for therapeutic targetingHaugen, M.H. / Boye, K. / Nesland, J.M. / Pettersen, S.J. / Egeland, E.V. / Tamhane, T. / Brix, K. / Maelandsmo, G.M. / Flatmark, K. et al. | 2015
- 18
-
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapyRuff, P. / Ferry, D.R. / Lakom, R. / Prausova, J. / Van Hazel, G.A. / Hoff, P.M. / Cunningham, D. / Arnold, D. / Schmoll, H.J. et al. | 2015
- 27
-
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancerBergmann, L. / Maute, L. / Heil, G. / Russel, J. / Weidmann, E. / Koberle, D. / Fuxius, S. / Weigang-Kohler, K. / Aulitzky, W.E. et al. | 2015
- 37
-
Identification of subjects at risk of proximal advanced neoplasia for colorectal cancer screeningWong, M.C.S. / Ching, J.Y.L. / Chan, V.C.W. / Lam, T.Y.T. / Luk, A.K.C. / Wong, S.H. / Ng, S.C. / Ng, S.S.M. / Wu, J.C.Y. et al. | 2015
- 45
-
Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2Oudard, S. / Culine, S. / Vano, Y. / Goldwasser, F. / Theodore, C. / Nguyen, T. / Voog, E. / Banu, E. / Vieillefond, A. et al. | 2015
- 55
-
Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: A stabilisation of an epidemic of viral induced carcinoma?Nasman, A. / Nordfors, C. / Holzhauser, S. / Vlastos, A. / Tertipis, N. / Hammar, U. / Hammarstedt-Nordenvall, L. / Marklund, L. / Munck-Wikland, E. et al. | 2015
- 62
-
Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literatureDel Fabbro, M. / Gallesio, G. / Mozzati, M. et al. | 2015
- 75
-
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapyLartigue, L. / Neuville, A. / Lagarde, P. / Brulard, C. / Rutkowski, P. / Tos, P.D. / Wardelmann, E. / Debiec-Rychter, M. / Italiano, A. et al. | 2015
- 84
-
The Collaborative Wilms Tumour Africa Project; Baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan AfricaPaintsil, V. / David, H. / Kambugu, J. / Renner, L. / Kouya, F. / Eden, T. / Hesseling, P. / Molyneux, E. / Israels, T. et al. | 2015
- 92
-
Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphomaEl-Mallawany, N.K. / Day, N. / Ayello, J. / Van de Ven, C. / Conlon, K. / Fermin, D. / Basrur, V. / Elenitoba-Johnson, K. / Lim, M. et al. | 2015
- 101
-
Evaluation of data quality in the National Prostate Cancer Register of SwedenTomic, K. / Sandin, F. / Wigertz, A. / Robinson, D. / Lambe, M. / Stattin, P. et al. | 2015
- 112
-
Increased breast cancer risk in in vitro fertilisation treated women with a multiple pregnancy: A new hypothesis based on historical in vitro fertilisation treatment dataOMEGA-project group / Krul, I.M. / Groeneveld, E. / Spaan, M. / van den Belt-Dusebout, A.W. / Mooij, T.M. / Hauptmann, M. / Twisk, J.W.R. / Lambers, M.J. et al. | 2015
- 121
-
The dramatic story of breast cancer in Iran: A reflection of the dangerous lifestyles from the glamorous WestDalfardi, B. et al. | 2015
- 127
-
Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise - A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of CancerSoft Tissue and Bone Sarcoma Group initiativeDesmoid Working Group / Kasper, B. / Baumgarten, C. / Bonvalot, S. / Haas, R. / Haller, F. / Hohenberger, P. / Moreau, G. / van der Graaf, W.T.A. et al. | 2015
- 137
-
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursSpicer, J. / Baird, R. / Suder, A. / Cresti, N. / Corbacho, J.G. / Hogarth, L. / Frenkel, E. / Matsumoto, S. / Kawabata, I. et al. | 2015
- 146
-
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumoursWeihrauch, M.R. / Richly, H. / von Bergwelt-Baildon, M.S. / Becker, H.J. / Schmidt, M. / Hacker, U.T. / Shimabukuro-Vornhagen, A. / Holtick, U. / Nokay, B. et al. | 2015
- 157
-
Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinomaHokuto, D. / Sho, M. / Yamato, I. / Yasuda, S. / Obara, S. / Nomi, T. / Nakajima, Y. et al. | 2015
- 166
-
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trialsFaron, M. / Pignon, J.P. / Malka, D. / Bourredjem, A. / Douillard, J.Y. / Adenis, A. / Elias, D. / Bouche, O. / Ducreux, M. et al. | 2015
- 177
-
Recurrence and cancer-specific survival according to the expression of IL-4R@a and IL-13R@a1 in patients with oral cavity cancerKwon, M. / Kim, J.W. / Roh, J.L. / Park, Y. / Cho, K.J. / Choi, S.H. / Nam, S.Y. / Kim, S.Y. / Lee, B.H. et al. | 2015
- 186
-
Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patientsColombo, C. / Miceli, R. / Le Pechoux, C. / Palassini, E. / Honore, C. / Stacchiotti, S. / Mir, O. / Casali, P.G. / Domont, J. et al. | 2015
- 193
-
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?Ben Arush, M. / Minard-Colin, V. / Mosseri, V. / Defachelles, A.S. / Bergeron, C. / Algret, N. / Fasola, S. / Andre, N. / Thebaud, E. et al. | 2015
- 202
-
Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysisFrench Sarcoma Group / Taieb, S. / Saada-Bouzid, E. / Tresch, E. / Ryckewaert, T. / Bompas, E. / Italiano, A. / Guillemet, C. / Peugniez, C. et al. | 2015
- 210
-
Tenosynovial giant cell tumourpigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitorsPalmerini, E. / Staals, E.L. / Maki, R.G. / Pengo, S. / Cioffi, A. / Gambarotti, M. / Picci, P. / Daolio, P.A. / Parafioriti, A. et al. | 2015
- 218
-
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancerVassal, G. / Rousseau, R. / Blanc, P. / Moreno, L. / Bode, G. / Schwoch, S. / Schrappe, M. / Skolnik, J. / Bergman, L. et al. | 2015
- 225
-
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - The United Kingdom experienceRenal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG) / Irtan, S. / Jitlal, M. / Bate, J. / Powis, M. / Vujanic, G. / Kelsey, A. / Walker, J. / Mitchell, C. et al. | 2015
- 233
-
Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centreKhoja, L. / McGurk, A. / O'Hara, C. / Chow, S. / Hasan, J. et al. | 2015
- 241
-
Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registriesAnttila, A. / Lonnberg, S. / Ponti, A. / Suonio, E. / Villain, P. / Coebergh, J.W. / von Karsa, L. et al. | 2015
- 252
-
ANKHD1 represses p21 (WAF1CIP1) promoter and promotes multiple myeloma cell growthDhyani, A. / Machado-Neto, J.A. / Favaro, P. / Saad, S.T.O. et al. | 2015
- 260
-
Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancersKang, L. / Sun, J. / Wen, X. / Cui, J. / Wang, G. / Hoffman, A.R. / Hu, J.F. / Li, W. et al. | 2015
- 271
-
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers InitiativeBogaerts, J. / Sydes, M.R. / Keat, N. / McConnell, A. / Benson, A. / Ho, A. / Roth, A. / Fortpied, C. / Eng, C. et al. | 2015
- 282
-
Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohortVos, E.L. / Jager, A. / Verhoef, C. / Voogd, A.C. / Koppert, L.B. et al. | 2015
- 292
-
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivorsEckhoff, L. / Knoop, AS. / Jensen, MB. / Ewertz, M. et al. | 2015
- 301
-
Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994BIG 1-00 phase III trialFei, F. / Messina, C. / Slaets, L. / Chakiba, C. / Cameron, D. / Bogaerts, J. / Bonnefoi, H. et al. | 2015
- 310
-
Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies - A population-based studyde Glas, N.A. / Bastiaannet, E. / de Craen, A.J.M. / van de Velde, C.J.H. / Siesling, S. / Liefers, G.J. / Portielje, J.E.A. et al. | 2015
- 317
-
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancerLUME-Lung 1 Study Group / Novello, S. / Kaiser, R. / Mellemgaard, A. / Douillard, J.Y. / Orlov, S. / Krzakowski, M. / von Pawel, J. / Gottfried, M. et al. | 2015
- 327
-
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizonsHollebecque, A. / Malka, D. / Ferte, C. / Ducreux, M. / Boige, V. et al. | 2015
- 340
-
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumourSatoh, T. / Aoki, Y. / Kasamatsu, T. / Ochiai, K. / Takano, M. / Watanabe, Y. / Kikkawa, F. / Takeshima, N. / Hatae, M. et al. | 2015
- 352
-
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trialMahner, S. / Meier, W. / du Bois, A. / Brown, C. / Lorusso, D. / Dell'Anna, T. / Cretin, J. / Havsteen, H. / Bessette, P. et al. | 2015
- 359
-
PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxelCoupe, N. / Corrie, P. / Hategan, M. / Larkin, J. / Gore, M. / Gupta, A. / Wise, A. / Suter, S. / Ciria, C. et al. | 2015
- 367
-
Treatment modifications in tumour necrosis factor-@a (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomasDeroose, J.P. / Grunhagen, D.J. / de Wilt, J.H.W. / Eggermont, A.M.M. / Verhoef, C. et al. | 2015
- 374
-
Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society studyFrezza, A.M. / Cesari, M. / Baumhoer, D. / Biau, D. / Bielack, S. / Campanacci, D.A. / Casanova, J. / Esler, C. / Ferrari, S. et al. | 2015
- 382
-
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patientsRoth, P. / Keller, A. / Hoheisel, J.D. / Codo, P. / Bauer, A.S. / Backes, C. / Leidinger, P. / Meese, E. / Thiel, E. et al. | 2015
- 391
-
Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: A prospected population based study in the south of The NetherlandsKlompenhouwer, E.G. / Voogd, A.C. / den Heeten, G.J. / Strobbe, L.J.A. / de Haan, A.F.J. / Wauters, C.A. / Broeders, M.J.M. / Duijm, L.E.M. et al. | 2015
- 400
-
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancerFakkert, I.E. / Abma, E.M. / Westrik, I.G. / Lefrandt, J.D. / Wolffenbuttel, B.H.R. / Oosterwijk, J.C. / Slart, R.H.J.A. / van der Veer, E. / de Bock, G.H. et al. | 2015
- 409
-
MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomasGattolliat, C.H. / Uguen, A. / Pesson, M. / Trillet, K. / Simon, B. / Doucet, L. / Robaszkiewicz, M. / Corcos, L. et al. | 2015
- 421
-
PD-L1 expression in small cell neuroendocrine carcinomasSchultheis, A.M. / Scheel, A.H. / Ozretic, L. / George, J. / Thomas, R.K. / Hagemann, T. / Zander, T. / Wolf, J. / Buettner, R. et al. | 2015
- 427
-
Evaluating iatrogenic prescribing: Development of an oncology-focused trigger toolHebert, G. / Netzer, F. / Ferrua, M. / Ducreux, M. / Lemare, F. / Minvielle, E. et al. | 2015
- 437
-
Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancerChan, R.J. / McCarthy, A.L. / Devenish, J. / Sullivan, K.A. / Chan, A. et al. | 2015
- 451
-
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trialLivi, L. / Meattini, I. / Marrazzo, L. / Simontacchi, G. / Pallotta, S. / Saieva, C. / Paiar, F. / Scotti, V. / De Luca Cardillo, C. et al. | 2015
- 464
-
Molecular mechanisms of constitutive and inducible NF-kappaB activation in oesophageal adenocarcinomaAbdel-Latif, M.M.M. / Kelleher, D. / Reynolds, J.V. et al. | 2015
- 473
-
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II studyDi Bartolomeo, M. / Ciarlo, A. / Bertolini, A. / Barni, S. / Verusio, C. / Aitini, E. / Pietrantonio, F. / Iacovelli, R. / Dotti, K.F. et al. | 2015
- 482
-
Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancerRyu, M.H. / Yoo, C. / Kim, J.G. / Ryoo, B.Y. / Park, Y.S. / Park, S.R. / Han, H.S. / Chung, I.J. / Song, E.K. et al. | 2015
- 489
-
Overall survival and renal function after partial and radical nephrectomy among older patients with localised renal cell carcinoma: A propensity-matched multicentre studyChung, J.S. / Son, N.H. / Lee, S.E. / Hong, S.K. / Lee, S.C. / Kwak, C. / Hong, S.H. / Kim, Y.J. / Kang, S.H. et al. | 2015
- 498
-
Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)van den Heuvel-Eibrink, M.M. / van Tinteren, H. / Bergeron, C. / Coulomb-L'Hermine, A. / de Camargo, B. / Leuschner, I. / Sandstedt, B. / Acha, T. / Godzinski, J. et al. | 2015
- 507
-
Efficacy of sunitinib in patients with metastatic or unresectable renal cell carcinoma and renal insufficiencyPoprach, A. / Bortlicek, Z. / Melichar, B. / Lakomy, R. / Svoboda, M. / Kiss, I. / Zemanova, M. / Fiala, O. / Kubackova, K. et al. | 2015
- 514
-
Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalenceTinhofer, I. / Johrens, K. / Keilholz, U. / Kaufmann, A. / Lehmann, A. / Weichert, W. / Stenzinger, A. / Stromberger, C. / Klinghammer, K. et al. | 2015
- 522
-
A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastomaWestphal, M. / Heese, O. / Steinbach, J.P. / Schnell, O. / Schackert, G. / Mehdorn, M. / Schulz, D. / Simon, M. / Schlegel, U. et al. | 2015
- 533
-
Glioblastoma in England: 2007-2011Brodbelt, A. / Greenberg, D. / Winters, T. / Williams, M. / Vernon, S. / Collins, V.P. et al. | 2015
- 543
-
Ovarian Sertoli Leydig cell tumours in children and adolescents: An analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT)Schneider, D.T. / Orbach, D. / Cecchetto, G. / Stachowicz-Stencel, T. / Brummel, B. / Brecht, I.B. / Bisogno, G. / Ferrari, A. / Reguerre, Y. et al. | 2015
- 551
-
Internet-based technologies to improve cancer care coordination: Current use and attitudes among cancer patientsGirault, A. / Ferrua, M. / Lalloue, B. / Sicotte, C. / Fourcade, A. / Yatim, F. / Hebert, G. / Di Palma, M. / Minvielle, E. et al. | 2015
- 558
-
Cancer incidence in participants in a long-distance ski race (Vasaloppet, Sweden) compared to the background populationHallmarker, U. / James, S. / Michaelsson, K. / Arnlov, J. / Sandin, F. / Holmberg, L. et al. | 2015
- 569
-
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: A randomised phase II trial of the Arbeitsgemeinschaft Internistische OnkologieLorenzen, S. / Riera Knorrenschild, J. / Haag, G.M. / Pohl, M. / Thuss-Patience, P. / Bassermann, F. / Helbig, U. / Weiszinger, F. / Schnoy, E. et al. | 2015
- 577
-
Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - A critical appraisalRocken, C. / Behrens, H.M. et al. | 2015
- 587
-
Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysisPietrantonio, F. / Petrelli, F. / Coinu, A. / Di Bartolomeo, M. / Borgonovo, K. / Maggi, C. / Cabiddu, M. / Iacovelli, R. / Bossi, I. et al. | 2015
- 595
-
Phase II study of pazopanib as second-line treatment after sunitinib in patients with metastatic renal cell carcinoma: A Southern China Urology Cancer Consortium TrialXie, M. / He, C.s. / Huang, J.K. / Lin, Q.z. et al. | 2015
- 604
-
Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomyOhwaki, K. / Endo, F. / Hattori, K. et al. | 2015
- 610
-
The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapyThurner, E.M. / Krenn-Pilko, S. / Langsenlehner, U. / Stojakovic, T. / Pichler, M. / Gerger, A. / Kapp, K.S. / Langsenlehner, T. et al. | 2015
- 620
-
Conservative surgery in ovarian borderline tumours: A meta-analysis with emphasis on recurrence riskVasconcelos, I. / de Sousa Mendes, M. et al. | 2015
- 632
-
Validation of methylation markers for diagnosis of oral cavity cancerArantes, L.M.R.B. / de Carvalho, A.C. / Melendez, M.E. / Centrone, C.C. / Gois-Filho, J.F. / Toporcov, T.N. / Caly, D.N. / Tajara, E.H. et al. | 2015
- 642
-
Vemurafenib for BRAF V600 mutated advanced melanoma: Results of treatment beyond progressionScholtens, A. / Geukes Foppen, M.H. / Blank, C.U. / van Thienen, J.V. / van Tinteren, H. / Haanen, J.B. et al. | 2015
- 653
-
Prospective evaluation of follow-up in melanoma patients in Germany - Results of a multicentre and longitudinal studyLivingstone, E. / Krajewski, C. / Eigentler, T.K. / Windemuth-Kieselbach, C. / Benson, S. / Elsenbruch, S. / Hauschild, A. / Rompel, R. / Meiss, F. et al. | 2015
- 668
-
Stereotactic body radiation therapy for lung metastases from soft tissue sarcomaNavarria, P. / Ascolese, A.M. / Cozzi, L. / Tomatis, S. / D'Agostino, G.R. / De Rose, F. / De Sanctis, R. / Marrari, A. / Santoro, A. et al. | 2015
- 675
-
Increased risk of antidepressant use in childhood cancer survivors: A Danish population-based cohort studyLund, L.W. / Winther, J.F. / Cederkvist, L. / Andersen, K.K. / Dalton, S.O. / Appel, C.W. / Rechnitzer, C. / Schmiegelow, K. / Johansen, C. et al. | 2015
- 685
-
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer| 2015
- 697
-
Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude| 2015
- 705
-
Obesity in breast cancer - What is the risk factor?| 2015
- 721
-
Influence of censoring on conclusions of trials for women with metastatic breast cancer| 2015
- 725
-
The risk of prostate cancer for men on aspirin, statin or antidiabetic medications| 2015
- 734
-
A new method of surgical margin assuring for abdominal radical trachelectomy in frozen section| 2015
- 742
-
Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group| 2015
- 751
-
Distinct effects of anti-inflammatory and anti-thrombotic drugs on cancer characteristics at diagnosis| 2015
- 758
-
Are we ready to predict late effects? A systematic review of clinically useful prediction models| 2015
- 767
-
Relative mortality rates from incident chronic diseases among breast cancer survivors - A 14year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007| 2015
- 776
-
High-sensitivity HPV genotyping reveals near universal positivity in anal squamous cell carcinoma: different implications for vaccine prevention and prognosis| 2015
- 786
-
Plasma 25-hydroxyvitamin D levels and survival of colorectal cancer patients: A meta-analysis| 2015
- 791
-
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: Evaluation of concordance between genomic and transcriptional profilesVignot, S. / Lefebvre, C. / Frampton, G.M. / Meurice, G. / Yelensky, R. / Palmer, G. / Capron, F. / Lazar, V. / Hannoun, L. et al. | 2015
- 800
-
Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: A systematic review and pooled-analysisPetrelli, F. / Pietrantonio, F. / Cremolini, C. / Di Bartolomeo, M. / Coinu, A. / Lonati, V. / de Braud, F. / Barni, S. et al. | 2015
- 808
-
Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialNishikawa, K. / Fujitani, K. / Inagaki, H. / Akamaru, Y. / Tokunaga, S. / Takagi, M. / Tamura, S. / Sugimoto, N. / Shigematsu, T. et al. | 2015
- 817
-
Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up studyGarcia-Albeniz, X. / Chan, J.M. / Paciorek, A. / Logan, R.W. / Kenfield, S.A. / Cooperberg, M.R. / Carroll, P.R. / Hernan, M. et al. | 2015
- 825
-
Alopecia as surrogate marker for chemotherapy response in patients with primary epithelial ovarian cancer: A metaanalysis of four prospective randomised phase III trials with 5114 patientsSehouli, J. / Fotopoulou, C. / Erol, E. / Richter, R. / Reuss, A. / Mahner, S. / Lauraine, E.P. / Kristensen, G. / Herrstedt, J. et al. | 2015
- 833
-
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanomaSchadendorf, D. / Amonkar, M.M. / Stroyakovskiy, D. / Levchenko, E. / Gogas, H. / de Braud, F. / Grob, J.J. / Bondarenko, I. / Garbe, C. et al. | 2015
- 841
-
RETRA exerts anticancer activity in Ewing's sarcoma cells independent of their TP53 statusSonnemann, J. / Grauel, D. / Blumel, L. / Hentschel, J. / Marx, C. / Blumrich, A. / Focke, K. / Becker, S. / Wittig, S. et al. | 2015
- 852
-
Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinibLee, C.K. / Goldstein, D. / Gibbs, E. / Joensuu, H. / Zalcberg, J. / Verweij, J. / Casali, P.G. / Maki, R.G. / Cioffi, A. et al. | 2015
- 861
-
443 paediatric cases of malignant melanoma registered with the German Central Malignant Melanoma Registry between 1983 and 2011Brecht, I.B. / Garbe, C. / Gefeller, O. / Pfahlberg, A. / Bauer, J. / Eigentler, T.K. / Offenmueller, S. / Schneider, D.T. / Leiter, U. et al. | 2015
- 869
-
The forthcoming inexorable decline of cutaneous melanoma mortality in light-skinned populationsAutier, P. / Koechlin, A. / Boniol, M. et al. | 2015
- 879
-
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samplesWinterhoff, B. / Freyer, L. / Hammond, E. / Giri, S. / Mondal, S. / Roy, D. / Teoman, A. / Mullany, S.A. / Hoffmann, R. et al. | 2015
- 893
-
Mutation specific functions of EGFR result in a mutation-specific downstream pathway activationErdem-Eraslan, L. / Gao, Y. / Kloosterhof, N.K. / Atlasi, Y. / Demmers, J. / Sacchetti, A. / Kros, J.M. / Sillevis Smitt, P. / Aerts, J. et al. | 2015
- 907
-
Do participants in adjuvant breast cancer trials reflect the breast cancer patient population?Treweek, S. / Dryden, R. / McCowan, C. / Harrow, A. / Thompson, A.M. et al. | 2015
- 915
-
Population based study on sentinel node biopsy before or after neoadjuvant chemotherapy in clinically node negative breast cancer patients: Identification rate and influence on axillary treatmentvan der Heiden-van der Loo, M. / de Munck, L. / Sonke, G.S. / van Dalen, T. / van Diest, P.J. / van den Bongard, H.J.G.D. / Peeters, P.H.M. / Rutgers, E.J.T. et al. | 2015
- 922
-
Microsatellite instability, disease-free survival and role of tumour infiltrating lymphocytes (Invited editorial on 'Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicenter study')Lynch, H.T. / Lanspa, S.J. / Snyder, C.L. / Drescher, K.M. et al. | 2015
- 925
-
Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre studyTougeron, D. / Sickersen, G. / Mouillet, G. / Zaanan, A. / Trouilloud, I. / Coriat, R. / Aparicio, T. / Des Guetz, G. et al. | 2015
- 935
-
Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial)Yoshida, M. / Muro, K. / Tsuji, A. / Hamamoto, Y. / Yoshino, T. / Yoshida, K. / Shirao, K. / Miyata, Y. / Takahari, D. et al. | 2015
- 942
-
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialArgiles, G. / Saunders, M.P. / Rivera, F. / Sobrero, A. / Benson, A. / Guillen Ponce, C. / Cascinu, S. / Van Cutsem, E. / Macpherson, I.R. et al. | 2015
- 950
-
Cervical cancer screening in Europe: Quality assurance and organisation of programmesElfstrom, K.M. / Arnheim-Dahlstrom, L. / von Karsa, L. / Dillner, J. et al. | 2015
- 969
-
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activationHuang, D.S. / Wang, Z. / He, X.J. / Diplas, B.H. / Yang, R. / Killela, P.J. / Meng, Q. / Ye, Z.Y. / Wang, W. et al. | 2015
- 977
-
Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndromeDurno, C.A. / Sherman, P.M. / Aronson, M. / Malkin, D. / Hawkins, C. / Bakry, D. / Bouffet, E. / Gallinger, S. et al. | 2015
- 984
-
The power of phase II end-points for different possible mechanisms of action of an experimental treatmentWason, J.M.S. / Dentamaro, A. / Eisen, T.G. et al. | 2015
- 995
-
Response to letter commenting on ''Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)''van den Heuvel-Eibrink, M.M. / Pritchard-Jones, K. / van Tinteren, H. / Graf, N. et al. | 2015
- 997
-
EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluationCoebergh, J.W. / van den Hurk, C. / Rosso, S. / Comber, H. / Storm, H. / Zanetti, R. / Sacchetto, L. / Janssen-Heijnen, M. / Thong, M. et al. | 2015
- 1018
-
A basis for translational cancer research on aetiology, pathogenesis and prognosis: Guideline for standardised and population-based linkages of biobanks to cancer registriesDillner, J. et al. | 2015
- 1028
-
Cancer registration, public health and the reform of the European data protection framework: Abandoning or improving European public health research?on behalf of the Eurocourse Work Package 2 Group / Andersen, M.R. / Storm, H.H. et al. | 2015
- 1039
-
Uses of cancer registries for public health and clinical research in Europe: Results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010-2012Siesling, S. / Louwman, W.J. / Kwast, A. / van den Hurk, C. / O'Callaghan, M. / Rosso, S. / Zanetti, R. / Storm, H. / Comber, H. et al. | 2015
- 1050
-
EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees(R) in Europe: From roots to fruitsCoebergh, J.W. / van den Hurk, C. / Louwman, M. / Comber, H. / Rosso, S. / Zanetti, R. / Sacchetto, L. / Storm, H. / van Veen, E.B. et al. | 2015
- 1064
-
Registration of childhood cancer: Moving towards pan-European coverage?Steliarova-Foucher, E. / Stiller, C. / Colombet, M. / Kaatsch, P. / Zanetti, R. / Peris-Bonet, R. et al. | 2015
- 1080
-
Reprint of: Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registriesAnttila, A. / Lonnberg, S. / Ponti, A. / Suonio, E. / Villain, P. / Coebergh, J.W. / von Karsa, L. et al. | 2015
- 1082
-
Power analysis to detect time trends on population-based cancer registries data: When size really mattersZanetti, R. / Sera, F. / Sacchetto, L. / Coebergh, J.W. / Rosso, S. et al. | 2015
- 1091
-
Completeness and timeliness: Cancer registries couldshould improve their performanceZanetti, R. / Schmidtmann, I. / Sacchetto, L. / Binder-Foucard, F. / Bordoni, A. / Coza, D. / Ferretti, S. / Galceran, J. / Gavin, A. et al. | 2015
- 1099
-
Completeness and registration bias in PROCARE, a Belgian multidisciplinary project on cancer of the rectum with participation on a voluntary basisPROCARE / Jegou, D. / Penninckx, F. / Vandendael, T. / Bertrand, C. / Van Eycken, E. et al. | 2015
- 1109
-
Towards optimal clinical and epidemiological registration of haematological malignancies: Guidelines for recording progressions, transformations and multiple diagnosesGavin, A. / Rous, B. / Marcos-Gragera, R. / Middleton, R. / Steliarova-Foucher, E. / Maynadie, M. / Zanetti, R. / Visser, O. et al. | 2015
- 1123
-
Choosing the net survival method for cancer survival estimationSeppa, K. / Hakulinen, T. / Pokhrel, A. et al. | 2015
- 1130
-
Reprint of: Evaluation of data quality in the National Prostate Cancer Register of SwedenTomic, K. / Sandin, F. / Wigertz, A. / Robinson, D. / Lambe, M. / Stattin, P. et al. | 2015
- 1131
-
The European Cancer Observatory: A new data resourceSteliarova-Foucher, E. / O'Callaghan, M. / Ferlay, J. / Masuyer, E. / Rosso, S. / Forman, D. / Bray, F. / Comber, H. et al. | 2015
- 1144
-
Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010Lortet-Tieulent, J. / Renteria, E. / Sharp, L. / Weiderpass, E. / Comber, H. / Baas, P. / Bray, F. / Coebergh, J.W. / Soerjomataram, I. et al. | 2015
- 1164
-
Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer ObservatoryArnold, M. / Karim-Kos, H.E. / Coebergh, J.W. / Byrnes, G. / Antilla, A. / Ferlay, J. / Renehan, A.G. / Forman, D. / Soerjomataram, I. et al. | 2015
- 1188
-
Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt projectStorm, H.H. / Engholm, G. / Pritzkuleit, R. / Kejs, A.M.T. / Katalinic, A. / Dunst, J. / Hollander, N.H. et al. | 2015
- 1199
-
Reprint of: Cancer incidence and mortality patterns in South Eastern Europe in the last decade: Gaps persist compared with the rest of EuropeZnaor, A. / van den Hurk, C. / Primic-Zakelj, M. / Agius, D. / Coza, D. / Demetriou, A. / Dimitrova, N. / Eser, S. / Karakilinc, H. et al. | 2015
- 1201
-
Reprint of: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012Ferlay, J. / Steliarova-Foucher, E. / Lortet-Tieulent, J. / Rosso, S. / Coebergh, J.W.W. / Comber, H. / Forman, D. / Bray, F. et al. | 2015
- 1203
-
Survivorship after childhood cancer: PanCare: A European Network to promote optimal long-term carePanCare Network / Hjorth, L. / Haupt, R. / Skinner, R. / Grabow, D. / Byrne, J. / Karner, S. / Levitt, G. / Michel, G. et al. | 2015
- 1212
-
Fulvestrant with or without selumetinib, a MEK 12 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 2108Zaman, K. / Winterhalder, R. / Mamot, C. / Hasler-Strub, U. / Rochlitz, C. / Mueller, A. / Berset, C. / Wiliders, H. / Perey, L. et al. | 2015
- 1221
-
Variations in compliance to quality indicators by age for 41,871 breast cancer patients across Europe: A European Society of Breast Cancer Specialists database analysiseusomaDB Working Group / Kiderlen, M. / Ponti, A. / Tomatis, M. / Boelens, P.G. / Bastiaannet, E. / Wilson, R. / van de Velde, C.J.H. / Audisio, R.A. et al. | 2015
- 1231
-
Impact of early tumour shrinkage and resection on outcomes in patients with wild-type RAS metastatic colorectal cancerDouillard, J.Y. / Siena, S. / Peeters, M. / Koukakis, R. / Terwey, J.H. / Tabernero, J. et al. | 2015
- 1243
-
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerBokemeyer, C. / Kohne, C.H. / Ciardiello, F. / Lenz, H.J. / Heinemann, V. / Klinkhardt, U. / Beier, F. / Duecker, K. / van Krieken, J.H. et al. | 2015
- 1253
-
Streptozocin5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumoursDilz, L.M. / Denecke, T. / Steffen, I.G. / Prasad, V. / von Weikersthal, L.F. / Pape, U.F. / Wiedenmann, B. / Pavel, M. et al. | 2015
- 1263
-
Treatment-related differences in health related quality of life and disease specific symptoms among colon cancer survivors: Results from the population-based PROFILES registryVerhaar, S. / Vissers, P.A.J. / Maas, H. / van de Poll-Franse, L.V. / van Erning, F.N. / Mols, F. et al. | 2015
- 1274
-
Combination antiemetic therapy with aprepitantfosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trialMulti-center Clinical Study Group of Osaka, Colorectal Cancer Treatment Group (MCSGO) / Nishimura, J. / Satoh, T. / Fukunaga, M. / Takemoto, H. / Nakata, K. / Ide, Y. / Fukuzaki, T. / Kudo, T. et al. | 2015
- 1283
-
Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 studyon behalf of the Scandinavian Prostate Cancer Group / Thomsen, F.B. / Brasso, K. / Christensen, I.J. / Johansson, J.E. / Angelsen, A. / Tammela, T.L.J. / Iversen, P. et al. | 2015
- 1293
-
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: A systematic review and meta-analysis of clinical trials in advanced cancer patientsPowles, T. / Bracarda, S. / Chen, M. / Norry, E. / Compton, N. / Heise, M. / Hutson, T. / Harter, P. / Carpenter, C. et al. | 2015
- 1303
-
Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patientsCho, J.K. / Lee, G.J. / Yi, K.I. / Cho, K.S. / Choi, N. / Kim, J.S. / Kim, H. / Oh, D. / Choi, S.K. et al. | 2015
- 1312
-
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: The TRUSTS trialBui-Nguyen, B. / Butrynski, J.E. / Penel, N. / Blay, J.Y. / Isambert, N. / Milhem, M. / Kerst, J.M. / Reyners, A. et al. | 2015
- 1321
-
The impact of bevacizumab on health-related quality of life in patients treated for recurrent glioblastoma: Results of the randomised controlled phase 2 BELOB trialDirven, L. / van den Bent, M.J. / Bottomley, A. / van der Meer, N. / van der Holt, B. / Vos, M.J. / Walenkamp, A.M.E. / Beerepoot, L.V. et al. | 2015
- 1331
-
Old age as risk indicator for poor end-of-life care quality - A population-based study of cancer deaths from the Swedish Register of Palliative CareLindskog, M. / Tavelin, B. / Lundstrom, S. et al. | 2015
- 1340
-
Childhood height increases the risk of prostate cancer mortalityAarestrup, J. / Gamborg, M. / Cook, M.B. / Baker, J.L. et al. | 2015
- 1346
-
Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: Analyses based on 4,407,971 screening colonoscopiesBrenner, H. / Altenhofen, L. / Stock, C. / Hoffmeister, M. et al. | 2015
- 1355
-
Do we need randomised trials for rare cancers?Prasad, V. / Oseran, A. et al. | 2015
- 1358
-
Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trialMartelli, G. / Boracchi, P. / Guzzetti, E. / Marano, G. / Lozza, L. / Agresti, R. / Ferraris, C. / Piromalli, D. / Greco, M. et al. | 2015
- 1365
-
Cardiorespiratory fitness, C-reactive protein and lung cancer risk: A prospective population-based cohort studyPletnikoff, P.P. / Laukkanen, J.A. / Tuomainen, T.P. / Kauhanen, J. / Rauramaa, R. / Ronkainen, K. / Kurl, S. et al. | 2015
- 1371
-
First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive TumoursSpanish Cooperative Group for the Treatment of Digestive Tumours (TTD) / Sastre, J. / Massuti, B. / Pulido, G. / Guillen-Ponce, C. / Benavides, M. / Manzano, J.L. / Reboredo, M. / Rivera, F. et al. | 2015
- 1381
-
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancerGrunnet, M. / Christensen, I.J. / Lassen, U. / Jensen, L.H. / Lydolph, M. / Knox, J.J. / McNamara, M.G. / Jitlal, M. / Wasan, H. et al. | 2015
- 1389
-
microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysisFrampton, A.E. / Krell, J. / Jamieson, N.B. / Gall, T.M.H. / Giovannetti, E. / Funel, N. / Mato Prado, M. / Krell, D. / Habib, N.A. et al. | 2015
- 1405
-
Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17Brule, S.Y. / Jonker, D.J. / Karapetis, C.S. / O'Callaghan, C.J. / Moore, M.J. / Wong, R. / Tebbutt, N.C. / Underhill, Cr. / Yip, D. et al. | 2015
- 1415
-
A functional variant at miRNA-122 binding site in IL-1@a 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancerZhang, Y. / Sturgis, E.M. / Sun, Y. / Sun, C. / Wei, Q. / Huang, Z. / Li, G. et al. | 2015
- 1424
-
Adverse events of local treatment in long-term head and neck rhabdomyosarcoma survivors after external beam radiotherapy or AMORE treatmentSchoot, R.A. / Slater, O. / Ronckers, C.M. / Zwinderman, A.H. / Balm, A.J.M. / Hartley, B. / van den Brekel, M.W. / Gupta, S. / Saeed, P. et al. | 2015
- 1435
-
Long-term outcome in BRAF^V^6^0^0^E melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progressionPuzanov, I. / Amaravadi, R.K. / McArthur, G.A. / Flaherty, K.T. / Chapman, P.B. / Sosman, J.A. / Ribas, A. / Shackleton, M. / Hwu, P. et al. | 2015
- 1444
-
Childhood central nervous system tumours: Incidence and time trends in 13 Southern and Eastern European cancer registriesPapathoma, P. / Thomopoulos, T.P. / Karalexi, M.A. / Ryzhov, A. / Zborovskaya, A. / Dimitrova, N. / Zivkovic, S. / Eser, S. / Antunes, L. et al. | 2015
- 1456
-
A daunting challenge: Human Papillomavirus assays and cytology in primary cervical screening of women below age 30yearsRebolj, M. / Bonde, J. / Ejegod, D. / Preisler, S. / Rygaard, C. / Lynge, E. et al. | 2015
- 1467
-
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone diseaseDiel, I.J. / Body, J.J. / Stopeck, A.T. / Vadhan-Raj, S. / Spencer, A. / Steger, G. / von Moos, R. / Goldwasser, F. / Feng, A. et al. | 2015
- 1476
-
In regard to Livi et al. ''Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5year survival analysis of a phase 3 randomised controlled trial''Bhattacharjee, A. / Chakraborty, S. et al. | 2015
- 1478
-
Authors replyMeattini, I. / Saieva, C. / Livi, L. et al. | 2015
- 1481
-
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancerSonnenblick, A. / Francis, P.A. / Azim, H.A. / de Azambuja, E. / Nordenskjold, B. / Gutierez, J. / Quinaux, E. / Mastropasqua, M.G. / Ameye, L. et al. | 2015
- 1490
-
Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcomeGoldrat, O. / Kroman, N. / Peccatori, F.A. / Cordoba, O. / Pistilli, B. / Lidegaard, O. / Demeestere, I. / Azim, H.A. et al. | 2015
- 1497
-
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD studyElshof, L.E. / Tryfonidis, K. / Slaets, L. / van Leeuwen-Stok, A.E. / Skinner, V.P. / Dif, N. / Pijnappel, R.M. / Bijker, N. / Rutgers, E.J.Th. et al. | 2015
- 1511
-
Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064)EORTC-LCG / O'Brien, M.E.R. / Gaafar, R. / Hasan, B. / Menis, J. / Cufer, T. / Popat, S. / Woll, P.J. / Surmont, V. et al. | 2015
- 1529
-
Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?Australasian Lung Cancer Trials Group (ALTG) / Blinman, P. / Hughes, B. / Crombie, C. / Christmas, T. / Hudson, M. / Veillard, A.S. / Muljadi, N. / Millward, M. et al. | 2015
- 1538
-
Long-term quality of life after oesophagectomy with gastric conduit interposition for cancerAkkerman, R.D.L. / Haverkamp, L. / van Rossum, P.S.N. / van Hillegersberg, R. / Ruurda, J.P. et al. | 2015
- 1546
-
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trialSinn, M. / Riess, H. / Sinn, B.V. / Stieler, J.M. / Pelzer, U. / Striefler, J.K. / Oettle, H. / Bahra, M. / Denkert, C. et al. | 2015
- 1555
-
A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancerChu, F.M. / Sartor, O. / Gomella, L. / Rudo, T. / Somerville, M.C. / Hereghty, B. / Manyak, M.J. et al. | 2015
- 1570
-
Chemoradiotherapy regimens for locoregionally advanced nasopharyngeal carcinoma: A Bayesian network meta-analysisYan, M. / Kumachev, A. / Siu, L.L. / Chan, K.K.W. et al. | 2015
- 1580
-
A model for predicting clinical outcome in patients with human papillomavirus-positive tonsillar and base of tongue cancerTertipis, N. / Hammar, U. / Nasman, A. / Vlastos, A. / Nordfors, C. / Grun, N. / Ahrlund-Richter, A. / Sivars, L. / Haeggblom, L. et al. | 2015
- 1588
-
An open label, multicenter, phase II study of dovitinib in advanced thyroid cancerLim, S.M. / Chung, W.Y. / Nam, K.H. / Kang, S.W. / Lim, J.Y. / Kim, H.G. / Shin, S.H. / Sun, J.M. / Kim, S.G. et al. | 2015
- 1596
-
Baseline caspase activity predicts progression free survival of temsirolimus-treated head neck cancer patientsJohn, K. / Rosner, I. / Keilholz, U. / Gauler, T. / Bantel, H. / Grunwald, V. et al. | 2015
- 1603
-
MED12 and uterine smooth muscle oncogenesis: State of the art and perspectivesCroce, S. / Chibon, F. et al. | 2015
- 1611
-
Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgeryJoensuu, H. / Martin-Broto, J. / Nishida, T. / Reichardt, P. / Schoffski, P. / Maki, R.G. et al. | 2015
- 1618
-
Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor modelBaba, M. / Maeda, I. / Morita, T. / Inoue, S. / Ikenaga, M. / Matsumoto, Y. / Sekine, R. / Yamaguchi, T. / Hirohashi, T. et al. | 2015
- 1630
-
Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programmeGondos, A. / Krilaviciute, A. / Smailyte, G. / Ulys, A. / Brenner, H. et al. | 2015
- 1638
-
Interplay between microRNAs and WNT@b-catenin signalling pathway regulates epithelial-mesenchymal transition in cancerGhahhari, N.M. / Babashah, S. et al. | 2015
- 1650
-
Note of clarification of data on the association between CYP2E1 RsaI polymorphism and lung cancer riskZhai, W. / Feng, R. / Yang, H. / Wang, Y. et al. | 2015
- 1657
-
Duration of Trastuzumab. In matters of the heart, one size may not fit all?Simmons, Christine / Dent, Susan / Brezden-Masley, Christine et al. | 2015
- 1660
-
Cardiac toxicity events in the PHARE trial, an adjuvant trastuzumab randomised phase III studyPivot, Xavier / Suter, Thomas / Nabholtz, Jean Marc / Pierga, Jean Yves / Espie, Marc / Lortholary, Alain / Khayat, David / Pauporte, Iris / Romieu, Gilles / Kramar, Andrew et al. | 2015
- 1667
-
Management of breast cancer after Hodgkin's lymphoma and paediatric cancerTerenziani, M. / Massimino, M. / Magazzu, D. / Gandola, L. / Capri, G. / Carcangiu, M.L. / Catania, S. / Di Russo, A. / Gennaro, M. et al. | 2015
- 1675
-
Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage diseaseOrsini, Ricardo G. / Verhoeven, Rob H.A. / Lemmens, Valery E.P.P. / van Steenbergen, Liza N. / de Hingh, Ignace H.J.T. / Nieuwenhuijzen, Grard A.P. / Rutten, Harm J.T. et al. | 2015
- 1683
-
Early surgery for failure after chemoradiation in operable thoracic oesophageal cancer. Analysis of the non-randomised patients in FFCD 9102 phase III trial: Chemoradiation followed by surgery versus chemoradiation aloneVincent, J. / Mariette, C. / Pezet, D. / Huet, E. / Bonnetain, F. / Bouche, O. / Conroy, T. / Roullet, B. / Seitz, J.F. et al. | 2015
- 1694
-
Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: Effective intervention in patients with luminal diseaseLamarca, A. / Benafif, S. / Ross, P. / Bridgewater, J. / Valle, J.W. et al. | 2015
- 1704
-
Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trialsPeeters, M. / Kafatos, G. / Taylor, A. / Gastanaga, V.M. / Oliner, K.S. / Hechmati, G. / Terwey, J.-H. / van Krieken, J.H. et al. | 2015
- 1714
-
A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancerHussain, Maha / Rathkopf, Dana / Liu, Glenn / Armstrong, Andrew / Kelly, Wm. Kevin / Ferrari, Anna / Hainsworth, John / Joshi, Adarsh / Hozak, Rebecca R. / Yang, Ling et al. | 2015
- 1725
-
Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseasesEOTTD group / Bolze, P.A. / Attia, J. / Massardier, J. / Seckl, M.J. / Massuger, L. / van Trommel, N. / Niemann, I. / Hajri, T. et al. | 2015
- 1732
-
Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesionsSerrano, B. / de Sanjose, S. / Tous, S. / Quiros, B. / Munoz, N. / Bosch, X. / Alemany, L. et al. | 2015
- 1742
-
Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer - A pooled analysis of PORTEC 1 and 2 trialsBosse, T. / Peters, E.E.M. / Creutzberg, C.L. / Jurgenliemk-Schulz, I.M. / Jobsen, J.J. / Mens, J.W.M. / Lutgens, L.C.H.W. / van der Steen-Banasik, E.M. / Smit, V.T.H.B.M. et al. | 2015
- 1751
-
Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic reviewLi, Xiaoqi / Li, Jin / Wu, Xiaohua et al. | 2015
- 1760
-
Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic areaHuang, Pei-Yu / Zeng, Qi / Cao, Ka-Jia / Guo, Xiang / Guo, Ling / Mo, Hao-Yuan / Wu, Pei-Hong / Qian, Chao-Nan / Mai, Hai-Qiang / Hong, Ming-Huang et al. | 2015
- 1771
-
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification systemYou, Rui / Zou, Xiong / Wang, Shun-Lan / Jiang, Rou / Tang, Lin-Quan / Zhang, Wei-Dong / Li, Li / Zhang, Meng-Xia / Shen, Guo-Ping / Guo, Ling et al. | 2015
- 1780
-
Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanomaTejera-Vaquerizo, A. / Nagore, E. / Puig, S. / Robert, C. / Saiag, P. / Martin-Cuevas, P. / Gallego, E. / Herrera-Acosta, E. / Aguilera, J. et al. | 2015
- 1794
-
A randomised, open-label, phase II study of neoadjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcomaDavis, E.J. / Chugh, R. / Zhao, L. / Lucas, D.R. / Biermann, J.S. / Zalupski, M.M. / Feng, M. / Wong, S.L. / Jacobson, J. et al. | 2015
- 1803
-
Spectrum of gene mutations detected by next generation exome sequencing in brain metastases of lung adenocarcinomaPreusser, M. / Berghoff, A.S. / Koller, R. / Zielinski, C.C. / Hainfellner, J.A. / Liebmann-Reindl, S. / Popitsch, N. / Geier, C.B. / Streubel, B. et al. | 2015
- 1812
-
Hypocalcaemia in patients with metastatic bone disease treated with denosumabBody, Jean-Jacques / Bone, Henry G. / de Boer, Richard H. / Stopeck, Alison / Van Poznak, Catherine / Damião, Ronaldo / Fizazi, Karim / Henry, David H. / Ibrahim, Toni / Lipton, Allan et al. | 2015
- 1822
-
Elimination of primary tumours and control of metastasis with rationally designed bacteriochlorin photodynamic therapy regimensRocha, L.B. / Gomes-da-Silva, L.C. / Dabrowski, J.M. / Arnaut, L.G. et al. | 2015
- 1831
-
Molecular changes in endometriosis-associated ovarian clear cell carcinomaWorley, M.J. / Liu, S. / Hua, Y. / Kwok, J.S.L. / Samuel, A. / Hou, L. / Shoni, M. / Lu, S. / Sandberg, E.M. et al. | 2015
- 1843
-
Differences in cancer drug assessment between Spain and the United KingdomLozano-Blázquez, Ana / Dickson, Rumona / Fraga-Fuentes, María-Dolores / Martínez-Martínez, Fernando / Calleja-Hernández, Miguel-Ángel et al. | 2015
- 1853
-
PD-L1 expression in small cell lung cancerKomiya, T. / Madan, R. et al. | 2015
- 1857
-
^9^0Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesPicozzi, V.J. / Ramanathan, R.K. / Lowery, M.A. / Ocean, A.J. / Mitchel, E.P. / O'Neil, B.H. / Guarino, M.J. / Conkling, P.R. / Cohen, S.J. et al. | 2015
- 1865
-
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumoursPiha-Paul, S.A. / Munster, P.N. / Hollebecque, A. / Argilés, G. / Dajani, O. / Cheng, J.D. / Wang, R. / Swift, A. / Tosolini, A. / Gupta, S. et al. | 2015
- 1874
-
Time to initiation of adjuvant chemotherapy in patients with rapidly proliferating early breast cancerFarolfi, Alberto / Scarpi, Emanuela / Rocca, Andrea / Mangia, Anita / Biglia, Nicoletta / Gianni, Lorenzo / Tienghi, Amelia / Valerio, Maria Rosaria / Gasparini, Giampietro / Amaducci, Laura et al. | 2015
- 1882
-
MRI and intraoperative pathology to predict nipple–areola complex (NAC) involvement in patients undergoing NAC-sparing mastectomyPonzone, Riccardo / Maggiorotto, Furio / Carabalona, Silvia / Rivolin, Alessandro / Pisacane, Alberto / Kubatzki, Franziska / Renditore, Stefania / Carlucci, Salvatore / Sgandurra, Paola / Marocco, Francesco et al. | 2015
- 1890
-
Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitorsBrier, M.J. / Chambless, D. / Gross, R. / Su, H.I. / DeMichele, A. / Mao, J.J. et al. | 2015
- 1897
-
Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsRakha, Emad / Pajares, Maria J. / Ilie, Marius / Pio, Ruben / Echeveste, Jose / Hughes, Elisha / Soomro, Irshad / Long, Elodie / Idoate, Miguel A. / Wagner, Susanne et al. | 2015
- 1904
-
A prospective, multicentre phase II trial of low-dose erlotinib in non-small cell lung cancer patients with EGFR mutations pretreated with chemotherapy: Thoracic Oncology Research Group 0911Yamada, K. / Aono, H. / Hosomi, Y. / Okamoto, H. / Kato, T. / Komase, Y. / Nishikawa, M. / Azuma, K. / Takeoka, H. et al. | 2015
- 1911
-
PanGen-Fam: Spanish registry of hereditary pancreatic cancerMocci, E. / Guillen-Ponce, C. / Earl, J. / Marquez, M. / Solera, J. / Salazar-Lopez, M.T. / Calcedo-Arnaiz, C. / Vazquez-Sequeiros, E. / Montans, J. et al. | 2015
- 1918
-
Impact of age on the feasibility and efficacy of neoadjuvant chemotherapy in patients with locally advanced oesophagogastric cancerSylvie, L. / Silvia, S. / Salah-Eddin, A.B. / Markus, F. / Florian, L. / Peter, T.P. / Bernhard, H. / Martin, A. / Alexander, N. et al. | 2015
- 1927
-
Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)Heinemann, Volker / Stintzing, Sebastian / Modest, Dominik P. / Giessen-Jung, Clemens / Michl, Marlies / Mansmann, Ulrich R. et al. | 2015
- 1937
-
Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic targetGo, H. / Kim, P.J. / Jeon, Y.K. / Cho, Y.M. / Kim, K. / Park, B.H. / Ku, J.Y. et al. | 2015
- 1946
-
Prior long response to androgen deprivation predicts response to next-generation androgen receptor axis targeted drugs in castration resistant prostate cancerLoriot, Yohann / Eymard, Jean-Christophe / Patrikidou, Anna / Ileana, Ecaterina / Massard, Christophe / Albiges, Laurence / Di Palma, Mario / Escudier, Bernard / Fizazi, Karim et al. | 2015
- 1953
-
CXC chemokine receptor 2 is associated with postoperative recurrence and survival of patients with non-metastatic clear-cell renal cell carcinomaAn, H. / Xu, L. / Chang, Y. / Zhu, Y. / Yang, Y. / Chen, L. / Lin, Z. / Xu, J. et al. | 2015
- 1962
-
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapyShiota, M. / Fujimoto, N. / Yokomizo, A. / Takeuchi, A. / Itsumi, M. / Inokuchi, J. / Tatsugami, K. / Uchiumi, T. / Naito, S. et al. | 2015
- 1970
-
The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancerIacovelli, R. / Verri, E. / Cossu Rocca, M. / Aurilio, G. / Cullura, D. / De Cobelli, O. / Nole, F. et al. | 2015
- 1978
-
Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, Koji / Hasegawa, Kosei / Yoshino, Kiyoshi / Murakami, Ryusuke / Hisamatsu, Takeshi / Stone, Rebecca L. / Previs, Rebecca A. / Hansen, Jean M. / Ikeda, Yuji / Miyara, Akiko et al. | 2015
- 1989
-
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guidelineEuropean Dermatology Forum (EDF) / European Association of Dermato-Oncology (EADO) / European Organization for Research and Treatment of Cancer (EORTC) / Stratigos, A. / Garbe, C. / Lebbe, C. / Malvehy, J. / del Marmol, V. / Pehamberger, H. et al. | 2015
- 2008
-
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemiaStumpel, D.J.P.M. / Schneider, P. / Pieters, R. / Stam, R.W. et al. | 2015
- 2022
-
Carboplatin therapeutic monitoring in preterm and full-term neonatesVeal, Gareth J. / Errington, Julie / Hayden, James / Hobin, David / Murphy, Dermot / Dommett, Rachel M. / Tweddle, Deborah A. / Jenkinson, Helen / Picton, Susan et al. | 2015
- 2031
-
Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trialSchoot, R.A. / van Ommen, C.H. / Stijnen, T. / Tissing, W.J.E. / Michiels, E. / Abbink, F.C.H. / Raphael, M.F. / Heij, H.A. / Lieverst, J.A. et al. | 2015
- 2039
-
Trends in survival for teenagers and young adults with cancer in the UK 1992–2006O'Hara, C. / Moran, A. / Whelan, J.S. / Hough, R.E. / Stiller, C.A. / Stevens, M.C.G. / Stark, D.P. / Feltbower, R.G. / McCabe, M.G. et al. | 2015
- 2049
-
Unmet needs and depression among carers of people newly diagnosed with cancerHeckel, L. / Fennell, K.M. / Reynolds, J. / Osborne, R.H. / Chirgwin, J. / Botti, M. / Ashley, D.M. / Livingston, P.M. et al. | 2015
- 2058
-
A review of breast cancer awareness among women in India: Cancer literate or awareness deficit?Gupta, A. / Shridhar, K. / Dhillon, P.K. et al. | 2015
- 2067
-
Similar anatomical distributions of childhood naevi and cutaneous melanoma in young adults residing in northern and southern SwedenKarlsson, Maria A. / Rodvall, Ylva / Wahlgren, Carl-Fredrik / Wiklund, Kerstin / Lindelöf, Bernt et al. | 2015
- 2076
-
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemiaPereira, J.K.N. / Machado-Neto, J.A. / Lopes, M.R. / Morini, B.C. / Traina, F. / Costa, F.F. / Saad, S.T.O. / Favaro, P. et al. | 2015
- 2086
-
Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumabValpione, S. / Martinoli, C. / Fava, P. / Mocellin, S. / Campana, L.G. / Quaglino, P. / Ferrucci, P.F. / Pigozzo, J. / Astrua, C. / Testori, A. et al. | 2015
- 2095
-
Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950–7van Rossum, Peter S.N. / Goense, Lucas / van Hillegersberg, Richard / Ruurda, Jelle P. et al. | 2015
- 2095
-
Comment on: Holscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7van Rossum, P.S.N. / Goense, L. / van Hillegersberg, R. / Ruurda, J.P. et al. | 2015
- 2097
-
Reply to the Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950–7Bollschweiler, Elfriede / Hölscher, Arnulf H. et al. | 2015
- 2097
-
Reply to the Comment on: Holscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7Bollschweiler, E. / Holscher, A.H. et al. | 2015
- 2099
-
Tribute to Arduino VerdecchiaRoberta, De Angelis et al. | 2015
- 2101
-
Cancer survival in Europe, 1999–2007: Doing better, feeling worse?Sant, Milena / Minicozzi, Pamela / Primic-Žakelj, Maja / Otter, Renee / Francisci, Silvia / Gatta, Gemma / Berrino, Franco / De Angelis, Roberta et al. | 2015
- 2104
-
The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methodsRossi, Silvia / Baili, Paolo / Capocaccia, Riccardo / Caldora, Massimiliano / Carrani, Eugenio / Minicozzi, Pamela / Pierannunzio, Daniela / Santaquilani, Mariano / Trama, Annalisa / Allemani, Claudia et al. | 2015
- 2120
-
Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based studyBaili, Paolo / Di Salvo, Francesca / Marcos-Gragera, Rafael / Siesling, Sabine / Mallone, Sandra / Santaquilani, Mariano / Micheli, Andrea / Lillini, Roberto / Francisci, Silvia et al. | 2015
- 2130
-
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based studyGatta, Gemma / Botta, Laura / Sánchez, María José / Anderson, Lesley Ann / Pierannunzio, Daniela / Licitra, Lisa et al. | 2015
- 2144
-
Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5Anderson, L.A. / Tavilla, A. / Brenner, H. / Luttmann, S. / Navarro, C. / Gavin, A.T. / Holleczek, B. / Johnston, B.T. / Cook, M.B. / Bannon, F. et al. | 2015
- 2158
-
On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 studyHolleczek, Bernd / Rossi, Silvia / Domenic, Agius / Innos, Kaire / Minicozzi, Pamela / Francisci, Silvia / Hackl, Monika / Eisemann, Nora / Brenner, Hermann et al. | 2015
- 2169
-
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5Lepage, Côme / Capocaccia, Riccardo / Hackl, Monika / Lemmens, Valerie / Molina, Esther / Pierannunzio, Daniela / Sant, Milena / Trama, Annalisa / Faivre, Jean et al. | 2015
- 2179
-
Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 studyCrocetti, Emanuele / Mallone, Sandra / Robsahm, Trude Eid / Gavin, Anna / Agius, Domenic / Ardanaz, Eva / Lopez, Maria-Dolores Chirlaque / Innos, Kaire / Minicozzi, Pamela / Borgognoni, Lorenzo et al. | 2015
- 2191
-
Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 studySant, Milena / Chirlaque Lopez, Maria Dolores / Agresti, Roberto / Sánchez Pérez, Maria José / Holleczek, Bernd / Bielska-Lasota, Magdalena / Dimitrova, Nadya / Innos, Kaire / Katalinic, Alexander / Langseth, Hilde et al. | 2015
- 2206
-
Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 studyTrama, Annalisa / Foschi, Roberto / Larrañaga, Nerea / Sant, Milena / Fuentes-Raspall, Rafael / Serraino, Diego / Tavilla, Andrea / Van Eycken, Liesbet / Nicolai, Nicola et al. | 2015
- 2217
-
Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5Marcos-Gragera, Rafael / Mallone, Sandra / Kiemeney, Lambertus A. / Vilardell, Loreto / Malats, Núria / Allory, Yves / Sant, Milena et al. | 2015
- 2231
-
Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 studyVisser, Otto / Ardanaz, Eva / Botta, Laura / Sant, Milena / Tavilla, Andrea / Minicozzi, Pamela et al. | 2015
- 2242
-
Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 studyFrancisci, Silvia / Minicozzi, Pamela / Pierannunzio, Daniela / Ardanaz, Eva / Eberle, Andrea / Grimsrud, Tom K. / Knijn, Arnold / Pastorino, Ugo / Salmerón, Diego / Trama, Annalisa et al. | 2015
- 2254
-
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based studyDe Angelis, Roberta / Minicozzi, Pamela / Sant, Milena / Dal Maso, Luigino / Brewster, David H. / Osca-Gelis, Gemma / Visser, Otto / Maynadié, Marc / Marcos-Gragera, Rafael / Troussard, Xavier et al. | 2015
- 2269
-
The role of censoring on progression free survival: Oncologist discretion advisedPrasad, Vinay / Bilal, Usama et al. | 2015
- 2272
-
Non-invasive, serum DNA pregnancy testing leading to incidental discovery of cancer: A good thing?Prasad, Vinay et al. | 2015
- 2275
-
A phase I study of daily afatinib, an irreversible ErbB family blocker, in combination with weekly paclitaxel in patients with advanced solid tumoursSuder, A. / Ang, J.E. / Kyle, F. / Harris, D. / Rudman, S. / Kristeleit, R. / Solca, F. / Uttenreuther-Fischer, M. / Pemberton, K. / Pelling, K. et al. | 2015
- 2285
-
Optimal breast cancer pathology manifestoTot, T. / Viale, G. / Rutgers, E. / Bergsten-Nordström, E. / Costa, A. et al. | 2015
- 2289
-
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: Results from a multicenter study in ItalySilvestri, Valentina / Rizzolo, Piera / Scarnò, Marco / Chillemi, Giovanni / Navazio, Anna Sara / Valentini, Virginia / Zelli, Veronica / Zanna, Ines / Saieva, Calogero / Masala, Giovanna et al. | 2015
- 2296
-
Addressing overtreatment of screen detected DCIS; the LORIS trialFrancis, Adele / Thomas, Jeremy / Fallowfield, Lesley / Wallis, Matthew / Bartlett, John M.S. / Brookes, Cassandra / Roberts, Tracy / Pirrie, Sarah / Gaunt, Claire / Young, Jennie et al. | 2015
- 2304
-
Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapyAlkner, Sara / Ehinger, Anna / Bendahl, Pär-Ola / Rydén, Lisa / Fernö, Mårten et al. | 2015
- 2314
-
Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysisYamaguchi, Norihiro / Fujii, Takeo / Aoi, Shunsuke / Kozuch, Peter S. / Hortobagyi, Gabriel N. / Blum, Ronald H. et al. | 2015
- 2321
-
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerGiaccone, G. / Bazhenova, L.A. / Nemunaitis, J. / Tan, M. / Juhász, E. / Ramlau, R. / van den Heuvel, M.M. / Lal, R. / Kloecker, G.H / Eaton, K.D. et al. | 2015
- 2330
-
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: Results by performance status, EGFR mutation, histology and response to previous inductionTan, Pui San / Lopes, Gilberto / Acharyya, Sanchalika / Bilger, Marcel / Haaland, Benjamin et al. | 2015
- 2345
-
A systematic review of randomised controlled trials of radiotherapy for localised prostate cancerWolff, Robert F. / Ryder, Steve / Bossi, Alberto / Briganti, Alberto / Crook, Juanita / Henry, Ann / Karnes, Jeffrey / Potters, Louis / de Reijke, Theo / Stone, Nelson et al. | 2015
- 2368
-
Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: Results of a pooled analysis of non-interventional studiesAlbiges, Laurence / Kube, Ulrich / Eymard, Jean-Christophe / Schmidinger, Manuela / Bamias, Aristotelis / Kelkouli, Nadia / Mraz, Bernhard / Florini, Styliani / Guderian, Gernot / Cattaneo, Agnese et al. | 2015
- 2375
-
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trialsVerdoodt, F. / Jentschke, M. / Hillemanns, P. / Racey, C.S. / Snijders, P.J.F. / Arbyn, M. et al. | 2015
- 2386
-
Concurrent Etoposide, Steroid, High-dose Ara-C and Platinum chemotherapy with radiation therapy in localised extranodal natural killer (NK)/T-cell lymphoma, nasal typeMichot, Jean-Marie / Mazeron, Renaud / Danu, Alina / Lazarovici, Julien / Ghez, David / Antosikova, Anna / Willekens, Christophe / Chamseddine, Ali N. / Minard, Veronique / Dartigues, Peggy et al. | 2015
- 2396
-
Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guidelineLebbe, Celeste / Becker, Jürgen C. / Grob, Jean-Jacques / Malvehy, Josep / del Marmol, Veronique / Pehamberger, Hubert / Peris, Ketty / Saiag, Philippe / Middleton, Mark R. / Bastholt, Lars et al. | 2015
- 2404
-
Uveal Melanoma UK National GuidelinesNathan, P. / Cohen, V. / Coupland, S. / Curtis, K. / Damato, B. / Evans, J. / Fenwick, S. / Kirkpatrick, L. / Li, O. / Marshall, E. et al. | 2015
- 2413
-
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomasGounder, Mrinal / Desai, Ved / Kuk, Deborah / Agaram, Narasimhan / Arcila, Maria / Durham, Benjamin / Keohan, Mary L. / Dickson, Mark A. / D'Angelo, Sandra P. / Shukla, Neerav et al. | 2015
- 2423
-
The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal TumoursBarrios, Carlos H. / Blackstein, Martin E. / Blay, Jean-Yves / Casali, Paolo G. / Chacon, Matias / Gu, Jin / Kang, Yoon-Koo / Nishida, Toshirou / Purkayastha, Das / Woodman, Richard C. et al. | 2015
- 2434
-
Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocolvon Bueren, André O. / Friedrich, Carsten / von Hoff, Katja / Kwiecien, Robert / Müller, Klaus / Pietsch, Torsten / Warmuth-Metz, Monika / Hau, Peter / Benesch, Martin / Kuehl, Joachim et al. | 2015
- 2444
-
Thymoma and thymic carcinoma in children and adolescents: A report from the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT)Stachowicz-Stencel, Teresa / Orbach, Daniel / Brecht, Ines / Schneider, Dominik / Bien, Ewa / Synakiewicz, Anna / Rod, Julien / Ferrari, Andrea / Cecchetto, Giovanni / Bisogno, Gianni et al. | 2015
- 2453
-
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: Secondary analysis of the Euro-Ewing99-R1 trialvan den Berg, Henk / Paulussen, Michael / Le Teuff, Gwénaël / Judson, Ian / Gelderblom, Hans / Dirksen, Uta / Brennan, Bernadette / Whelan, Jeremy / Ladenstein, Ruth Lydia / Marec-Berard, Perrine et al. | 2015
- 2465
-
Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)Zhou, Margaret J. / Doral, Michelle Y. / DuBois, Steven G. / Villablanca, Judith G. / Yanik, Gregory A. / Matthay, Katherine K. et al. | 2015
- 2473
-
Low cancer suspicion following experience of a cancer 'warning sign'Whitaker, Katriina L. / Winstanley, Kelly / Macleod, Una / Scott, Suzanne E. / Wardle, Jane et al. | 2015
- 2480
-
Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cellsTokunaga, Yoshimasa / Liu, Dage / Nakano, Jun / Zhang, Xia / Nii, Kazuhito / Go, Tetsuhiko / Huang, Cheng-long / Yokomise, Hiroyasu et al. | 2015
- 2491
-
Oral single-agent chemotherapy in older patients with solid tumours: A position paper from the International Society of Geriatric Oncology (SIOG)Biganzoli, L. / Lichtman, S. / Michel, J.-P. / Papamichael, D. / Quoix, E. / Walko, C. / Aapro, M. et al. | 2015
- 2501
-
Correlation of single arm versus randomised phase 2 oncology trial characteristics with phase 3 outcomeMonzon, Jose G. / Hay, Annette E. / McDonald, Gail T. / Pater, Joseph L. / Meyer, Ralph M. / Chen, Eric / Chen, Bingshu E. / Dancey, Janet E. et al. | 2015
- 2508
-
Survival of breast cancer patients with synchronous or metachronous central nervous system metastasesHo, V.K.Y. / Gijtenbeek, J.M.M. / Brandsma, D. / Beerepoot, L.V. / Sonke, G.S. / van der Heiden-van der Loo, M. et al. | 2015
- 2517
-
Cardiac assessment of early breast cancer patients 18years after treatment with cyclophosphamide-, methotrexate-, fluorouracil- or epirubicin-based chemotherapyde Azambuja, Evandro / Ameye, Lieveke / Diaz, Marie / Vandenbossche, Sandrine / Aftimos, Philippe / Hernández, Sara Bejarano / Shih-Li, Chao / Delhaye, François / Focan, Christian / Cornez, Nathalie et al. | 2015
- 2525
-
Improved inter-observer agreement of an expert review panel in an oncology treatment trial – Insights from a structured interventional processNestle, Ursula / Rischke, Hans Christian / Eschmann, Susanne Martina / Holl, Gabriele / Tosch, Marco / Miederer, Matthias / Plotkin, Michail / Essler, Markus / Puskas, Cornelia / Schimek-Jasch, Tanja et al. | 2015
- 2534
-
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based studyHendriks, L.E. / Derks, J.L. / Postmus, P.E. / Damhuis, R.A. / Houben, R.M.A. / Troost, E.G.C. / Hochstenbag, M.M. / Smit, E.F. / Dingemans, A.-M.C. et al. | 2015
- 2545
-
18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patientsElimova, Elena / Wang, Xuemei / Etchebehere, Elba / Shiozaki, Hironori / Shimodaira, Yusuke / Wadhwa, Roopma / Planjery, Venkatram / Charalampakis, Nikolaos / Blum, Mariela A. / Hofstetter, Wayne et al. | 2015
- 2553
-
Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancerBos, A.C.R.K. / van Erning, F.N. / van Gestel, Y.R.B.M. / Creemers, G.J.M. / Punt, C.J.A. / van Oijen, M.G.H. / Lemmens, V.E.P.P. et al. | 2015
- 2562
-
The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancervan Soest, R.J. / Nieuweboer, A.J.M. / de Morrée, E.S. / Chitu, D. / Bergman, A.M. / Goey, S.H. / Bos, M.M. / van der Meer, N. / Hamberg, P. / de Wit, R. et al. | 2015
- 2570
-
High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy settingAntoun, Sami / Bayar, Amine / Ileana, Ekatarina / Laplanche, Agnès / Fizazi, Karim / di Palma, Mario / Escudier, Bernard / Albiges, Laurence / Massard, Christophe / Loriot, Yohann et al. | 2015
- 2578
-
Tyrosine kinase inhibitors in renal cell cancer: Losing an empire and yet to find a roleEisen, Tim et al. | 2015
- 2580
-
Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinomaAlbiges, Laurence / Fay, André P. / Xie, Wanling / Krajewski, Katherine / McDermott, David F. / Heng, Daniel Y.C. / Dariane, Charles / DeVelasco, Guillermo / Lester, Renee / Escudier, Bernard et al. | 2015
- 2587
-
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-upZhang, Meng-Xia / Li, Jing / Shen, Guo-Ping / Zou, Xiong / Xu, Jun-Jie / Jiang, Rou / You, Rui / Hua, Yi-Jun / Sun, Ying / Ma, Jun et al. | 2015
- 2596
-
Induction chemotherapy prior to surgery with or without postoperative radiotherapy for oral cavity cancer patients: Systematic review and meta-analysisMarta, Gustavo N. / Riera, Rachel / Bossi, Paolo / Zhong, Lai-ping / Licitra, Lisa / Macedo, Cristiane R. / de Castro, Gilberto / Carvalho, André L. / William, William N. / Kowalski, Luis Paulo et al. | 2015
- 2604
-
Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guidelineSaiag, Philippe / Grob, Jean-Jacques / Lebbe, Celeste / Malvehy, Josep / del Marmol, Veronique / Pehamberger, Hubert / Peris, Ketty / Stratigos, Alexander / Middelton, Mark / Basholt, Lars et al. | 2015
- 2609
-
Imatinib in advanced chordoma: A retrospective case series analysisHindi, Nadia / Casali, Paolo G. / Morosi, Carlo / Messina, Antonella / Palassini, Elena / Pilotti, Silvana / Tamborini, Elena / Radaelli, Stefano / Gronchi, Alessandro / Stacchiotti, Silvia et al. | 2015
- 2615
-
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trialsDuffaud, F. / Sleijfer, S. / Litière, S. / Ray-Coquard, I. / Le Cesne, A. / Papai, Z. / Judson, I. / Schöffski, P. / Chawla, S.P. / Dewji, R. et al. | 2015
- 2624
-
CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patientsSand, L.G.L. / Scotlandi, K. / Berghuis, D. / Snaar-Jagalska, B.E. / Picci, P. / Schmidt, T. / Szuhai, K. / Hogendoorn, P.C.W. et al. | 2015
- 2634
-
Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacyPompe, Raisa S. / von Bueren, André O. / Mynarek, Martin / von Hoff, Katja / Friedrich, Carsten / Kwiecien, Robert / Treulieb, Wiebke / Lindow, Christine / Deinlein, Frank / Fleischhack, Gudrun et al. | 2015
- 2643
-
Survival patterns in teenagers and young adults with cancer in the United Kingdom: Comparisons with younger and older age groupsStark, Dan / Bowen, David / Dunwoodie, Elaine / Feltbower, Richard / Johnson, Rod / Moran, Anthony / Stiller, Charles / O'Hara, Catherine et al. | 2015
- 2655
-
Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?Boursi, Ben / Mamtani, Ronac / Haynes, Kevin / Yang, Yu-Xiao et al. | 2015
- 2665
-
Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983–2014): Gaps persist across 14 cancer registriesKaralexi, Maria A. / Papathoma, Paraskevi / Thomopoulos, Thomas P. / Ryzhov, Anton / Zborovskaya, Anna / Dimitrova, Nadya / Zivkovic, Snezana / Eser, Sultan / Antunes, Luís / Sekerija, Mario et al. | 2015
- 2678
-
Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapySpindler, Karen-Lise Garm / Pallisgaard, Niels / Appelt, Ane Lindegaard / Andersen, Rikke Fredslund / Schou, Jakob V. / Nielsen, Dorte / Pfeiffer, Per / Yilmaz, Mette / Johansen, Julia S. / Hoegdall, Estrid V. et al. | 2015
- 2686
-
How should we use anti-CTLA-4 antibodies?Marabelle, Aurélien / Eggermont, Alexander et al. | 2015
- 2689
-
Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumabEroglu, Zeynep / Kim, Dae Won / Wang, Xiaoyan / Camacho, Luis H. / Chmielowski, Bartosz / Seja, Elizabeth / Villanueva, Arturo / Ruchalski, Kathleen / Glaspy, John A. / Kim, Kevin B. et al. | 2015
- 2698
-
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areasKim, Sehui / Kim, Moon-Young / Koh, Jaemoon / Go, Heounjeong / Lee, Dong Soo / Jeon, Yoon Kyung / Chung, Doo Hyun et al. | 2015
- 2708
-
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983Tanis, Erik / Julié, Catherine / Emile, Jean-Francois / Mauer, Murielle / Nordlinger, Bernard / Aust, Daniela / Roth, Arnaud / Lutz, Manfred P. / Gruenberger, Thomas / Wrba, Fritz et al. | 2015
- 2718
-
Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.govPrasad, Vinay / Goldstein, Jeffery A. et al. | 2015
- 2725
-
A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibitionZucchini, G. / Armstrong, A.C. / Wardley, A.M. / Wilson, G. / Misra, V. / Seif, M. / Ryder, W.D. / Cope, J. / Blowers, E. / Howell, A. et al. | 2015
- 2732
-
The influence of industry sponsorship on the reporting of subgroup analyses within phase III randomised controlled trials in gastrointestinal oncologyBarton, Sarah / Peckitt, Clare / Sclafani, Francesco / Cunningham, David / Chau, Ian et al. | 2015
- 2740
-
Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancerLeon, Otilia / Guren, Marianne G. / Radu, Calin / Gunnlaugsson, Adalsteinn / Johnsson, Anders et al. | 2015
- 2747
-
Insulin resistance and endometrial cancer risk: A systematic review and meta-analysisHernandez, Adrian V. / Pasupuleti, Vinay / Benites-Zapata, Vicente A. / Thota, Priyaleela / Deshpande, Abhishek / Perez-Lopez, Faustino R. et al. | 2015
- 2759
-
Human papillomavirus genotype and oropharynx cancer survival in the United States of AmericaGoodman, Marc T. / Saraiya, Mona / Thompson, Trevor D. / Steinau, Martin / Hernandez, Brenda Y. / Lynch, Charles F. / Lyu, Christopher W. / Wilkinson, Edward J. / Tucker, Thomas / Copeland, Glenn et al. | 2015
- 2768
-
Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative studyGanly, Ian / Amit, Moran / Kou, Lei / Palmer, Frank L. / Migliacci, Jocelyn / Katabi, Nora / Yu, Changhong / Kattan, Michael W. / Binenbaum, Yoav / Sharma, Kanika et al. | 2015
- 2777
-
Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancerSchilling, Clare / Stoeckli, Sandro J. / Haerle, Stephan K. / Broglie, Martina A. / Huber, Gerhard F. / Sorensen, Jens Ahm / Bakholdt, Vivi / Krogdahl, Annelise / von Buchwald, Christian / Bilde, Anders et al. | 2015
- 2785
-
Prognostic score for patients with advanced melanoma treated with ipilimumabDiem, Stefan / Kasenda, Benjamin / Martin-Liberal, Juan / Lee, Alexander / Chauhan, Dharmisha / Gore, Martin / Larkin, James et al. | 2015
- 2792
-
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanismsJohnson, Douglas B. / Menzies, Alexander M. / Zimmer, Lisa / Eroglu, Zeynep / Ye, Fei / Zhao, Shilin / Rizos, Helen / Sucker, Antje / Scolyer, Richard A. / Gutzmer, Ralf et al. | 2015
- 2800
-
Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosisFiore, Marco / Colombo, Chiara / Radaelli, Stefano / Callegaro, Dario / Palassini, Elena / Barisella, Marta / Morosi, Carlo / Baldi, Giacomo G. / Stacchiotti, Silvia / Casali, Paolo G. et al. | 2015
- 2808
-
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsQuinten, Chantal / Coens, Corneel / Ghislain, Irina / Zikos, Efstathios / Sprangers, Mirjam A.G. / Ringash, Jolie / Martinelli, Francesca / Ediebah, Divine E. / Maringwa, John / Reeve, Bryce B. et al. | 2015
- 2820
-
Landscape of dietary factors associated with risk of gastric cancer: A systematic review and dose-response meta-analysis of prospective cohort studiesFang, Xuexian / Wei, Jiayu / He, Xuyan / An, Peng / Wang, Hao / Jiang, Li / Shao, Dandan / Liang, Han / Li, Yi / Wang, Fudi et al. | 2015
- 2833
-
Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?van der Leest, Robert J.T. / Zoutendijk, Judith / Nijsten, Tamar / Mooi, Wolter J. / van der Rhee, Jasper I. / de Vries, Esther / Hollestein, Loes M. et al. | 2015
- e1
-
OP0003 Feasibility and efficacy of neoadjuvant chemotherapy in locally advanced gastric cancer: A randomised trialAhmed, B.M. / Wani, K.A. / Wani, M. et al. | 2015
- e2
-
OP0009 Comparison of two fractionation schedules on quality of life and survival in patients with brain metastases: A randomised, double-blind trialSuresh Kumar, K. / Arun, P. et al. | 2015
- e4
-
OP0015 Polymorphisms in apoptosis-related genes and risk of HPV-mediated cervical cancer: A case-control studyAnkathil, R. / Tan, S.C. et al. | 2015
- e5
-
P0007 High-grade T1 bladder urothelial carcinoma: Optimal managementNassir, A. et al. | 2015
- e6
-
P0017 S100P regulates cytoskeleton dynamics to promote cell migration and metastasisDu, M. / Wang, G. / Barraclough, R. / Rudland, P. et al. | 2015
- e8
-
P0028 Isoliquiritigenin causes DNA damage and inhibits ATM expression in oral squamous cell carcinomaShieh, T.M. / Huang, Y.T. / Yu, C.C. / Hsia, S.M. / Shih, Y.H. / Wang, T.H. et al. | 2015
- e10
-
P0034 Pentafecta outcomes plus evaluation of immediate continence after robotic, extraperitoneal, radical prostatectomy with complete preservation of the Veil of AphroditeBoni, A. / Cochetti, G. / Barillaro, F. / Emanuele, C. / Lepri, E. / Mearini, E. et al. | 2015
- e12
-
P0053 Protease-activated receptor-2 in regulation of proliferation and invasion of oral squamous cell carcinoma cellsCheng, J. / Al-Eryani, K. / Abe, T. / Maruyama, S. / Yamazaki, M. / Babkair, H. / Saku, T. et al. | 2015
- e13
-
P0059 Effect of AT-101 and cisplatin on apoptosis in human non-small-cell lung cancer cells: Inhibition of APE1-activated IL-6STAT3 signalling pathwayRen, T. / Wang, D. et al. | 2015
- e14
-
P0066 Pretreatment serum carcinoembryonic antigen levels are associated with chemoradiation-induced downstaging and downsizing of rectal cancerKim, M.J. / Kim, E.S. / Min, C.K. / Yeo, S.G. et al. | 2015
- e15
-
P0073 Clinical characteristics of prostate cancer at a tertiary care medical centre in southern India over 11years: A retrospective analysisSinghal, U. / Chawla, A.K. / Thomas, J. / Hegde, P. et al. | 2015
- e16
-
P0078 Postoperative morbidity and mortality following D2 gastrectomy: An audit of 456 patientsSunil, B.J. / Seshadri, R.A. et al. | 2015
- e17
-
P0089 Prognostic factors for node-positive breast cancer after surgery, chemotherapy, and radiotherapyLiang, C.C. / Pi, C.P. et al. | 2015
- e18
-
P0094 Tumour budding in oral squamous cell carcinomas as a prognostic factorAttramadal, C.G. / Kumar, S. / Dhakal, H.P. / Boysen, M.E. / Nesland, J.M. / Bryne, M. et al. | 2015
- e21
-
P0108 Analysis of cytotoxic effects of selected smokeless tobacco productsJose, M. / Varghese, I. / Shantaram, M. et al. | 2015
- e23
-
P0115 Effect of differential stage or treatment on socioeconomic inequalities in survival from non-small-cell lung carcinoma (NSCLC): Mediation analysis using Osaka population-based cancer registry data in JapanRachet, B. / Ito, Y. / Li, R. / Ioka, A. / Nakayama, T. et al. | 2015
- e25
-
P0122 The unique pathological characteristics and prognostic significance of primary lung adenocarcinoma of 1cm or less in sizeZhang, Y.K. / Zhu, W.Y. / Wang, Z.Y. / Wang, S.J. / Zhou, K.Y. / Tan, L.L. / Le, H.B. et al. | 2015
- e28
-
P0143 Diagnostic possibilities of an echodopplerography in an assessment of prevalence of a tumoural invasion of a stomach cancerIsamukhamedova, M. / Pulatova, I.Z. et al. | 2015
- e29
-
P0155 Effect of pretreatment anaemia on outcomes of Chinese women with breast cancer receiving neoadjuvant chemotherapyZhu, W. / Xu, B. et al. | 2015
- e32
-
P0170 Trastuzumab for HER2-positive breast cancer: Experience from a middle-income Asian countryHo, G.F. / Mastura, M.Y. / Kaur, R.P. / Hoo, L.P. / Lim, T.O. et al. | 2015
- e33
-
P0175 Patients' perspectives on the current status of cancer pain management in AsiaTho, L.M. / Calimag, M.M.P. / Ahn, J.S. / Chao, T.C. / Ho, K.Y. / Kim, Y.C. / Xia, Z.J. / Ward, L. / Moon, H. et al. | 2015
- e34
-
P0184 Establishment of a cell microencapsulation model using mucoepidermoid carcinoma cellsGuo, L.j. / Pan, X.f. / Yang, S. / Loo, W.T. / C Chow, L.W. / Tsang, W. et al. | 2015
- e35
-
P0193Marsdenia tenacissima extract enhances gefitinib efficacy in non-small-cell lung cancer xenograftsHan, S.Y. / Zhao, W. / Sun, H. / Zhou, N. / Zhou, F. / An, G. / Li, P.P. et al. | 2015
- S1
-
Basic Science/Translational Research| 2015
- S1
-
102 IL-6 receptor antibody enhances the effect of TKI against renal cell carcinomaIshibashi, K. / Kubo, H. / Kojima, Y. / Haber, T. / Thüroff, J.W. / Brenner, W. et al. | 2015
- S2
-
ITOC2 - 006. Notch triggers myeloid reprogramming in murine pancreatic cancerFlorian, N. / David, K.G. / Dieter, S. / Roland, S.M. / Mathias, H.F. / Jens, S.T. et al. | 2015
- S2
-
105 Targeting phosphatidylserine-mediated immune suppression enhances the efficacy of immune checkpoint blockade in preclinical tumor models of melanoma and breastHutchins, J. / Freimark, B. / Brekken, R. / Huang, X. et al. | 2015
- S3
-
110 Linking glioblastoma multiforme microRNA profiles with a potential susceptibility to dendritic cell-based cancer immunotherapyErhart, F. / Dohnal, A. / Reitermeier, R. / Hack, M. / Hainfellner, J. / Felzmann, T. / Visus, C. et al. | 2015
- S3
-
Basic Science| 2015
- S4
-
ITOC2 - 012. Neoadjuvant immune checkpoint blockade for pancreatic cancer prevents local tumour recurrence through tissue resident antitumoural CD8+ CD103+ T cellsJennifer, B. / Bettina, F.M. / Norman, W. / Stefan, K. / Florian, K. / Engin, G. et al. | 2015
- S5
-
ITOC2 - 015. Therapy of hepatocellular carcinoma (HCC) with immunostimulatory RNA activating RIG-ILaura, P. / Igor, L. / Daniel, B. / Stephanie, H. / Stefan, E. / Peter, D. / Simon, R. / Max, S. et al. | 2015
- S6
-
ITOC2 - 017. Prolonged survival for patients with recurrent glioblastoma multiforme who are treated with tumour lysate-pulsed autologous dendritic cellsMarnix, B.L. / Robert, P.M. / Linda, L. et al. | 2015
- S7
-
ITOC2 - 020. VGX-3100 Immunotherapy for CIN23 Induces regression of cervical lesions and viral clearance (Phase II study): Implications for treatment of HPV associated cancersNiranjan, S. / Cornelia, T. / Matthew, M. / Xuefei, S. / Michael, D. / David, W. / Jean, B. / Jian, Y. / Jessica, L. et al. | 2015
- S8
-
ITOC2 - 023. Integrated computational pipeline for development of personalised melanoma vaccineTanushree, J. / Shailendra, G.Dr. / Jan, D.Dr. / Julio Vera, G.Pr. / Neils, S.Dr. / Beatrice, S.T.Dr. / Gerold, S.Pr. et al. | 2015
- S8
-
128 FTS (Fused Toes Homolog) silencing increases the effect of cisplatin through inhibiting EGFR-mediated repair of DNA damage in cervix cancer cellsPark, W.Y. / Ds, P. / Cinghu, S. / Yu, J.R. et al. | 2015
- S9
-
ITOC2 - 026. A new fusion receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapySebastian, K. / Simon, G. / Michael, C. / Christopher, L. / Fabian, K. / Simon, R. / Max, S. / Stefan, E. et al. | 2015
- S10
-
ITOC2 - 029. Combination of CTLA4-blockade, depletion of CD25+ cells and active-specific immunotherapy prolongs survival in murine melanomaJulia, K.R. / Peter, R. / Louis, B. / Rudolf, H.A. / Hauke, W. / Natasja, V.D.E.K. et al. | 2015
- S10
-
135 Nucleosome occupancy and epigenetic modifications in the alternative splicing site of ZNF518B gene in colorectal cancerRiffo-Campos, A.L. / Castillo, J. / Siscar-Lewin, S. / Vallet-Sanchez, A. / Lopez-Rodas, G. / Franco, L. et al. | 2015
- S11
-
139 The role of DOT1L in neuroblastomaWong, M. / Polly, P. / Liu, T. et al. | 2015
- S12
-
ITOC2 - 036. A method for developing predictive tests for immunotherapy benefitHeinrich, R. / Joanna, R. et al. | 2015
- S12
-
143 Evaluation of miR-708-5p expression and its role in osteosarcoma tumorigenesisBrassesco, M. / Delsin, L. / Fedatto, P. / Scrideli, C. / Tone, L. et al. | 2015
- S14
-
150 MicroRNA-199a and 214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumorKuninty, P.R. / Bojmar, L. / Sandström, P. / Storm, G. / Prakash, J. et al. | 2015
- S16
-
158 PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferationSaceda, M. / Fernandez-Ballester, G. / Encinar-Hidalgo, J.A. / Caruana, P. / Poveda-Delltel, M. / Lucero-Calabuig, P. / Garcia-Morales, P. / Martinez-Lacaci, I. et al. | 2015
- S17
-
161 Newly synthesized Zinc/Gold and Zinc/Silver complexes with Schiff-base ligands as potential anticancer agentsAlexandrova, R. / Zhivkova, T. / Abudalleh, A. / Dyakova, L. / Dinev, D. / Mitrenga, P. / Ivanov, D. / Toshkova, R. / Gavrilov, I. / Georgieva, M. et al. | 2015
- S18
-
165 PDL-1 is highly expressed on circulating epithelial tumor cells (CETCs) and could be a crucial factor in the inhibition of immune response to CETCs during metastasis formationPizon, M. / Zimon, D. / Maier, V. / Pachmann, U. / Pachmann, K. et al. | 2015
- S19
-
168 Mesenchymal stem cells protects ovarian cancer cells from chemotherapy through IL6 secretionGosset, M. / Geyl, C. / Mirshahi, M. / Maleki, M. / Rafii, A. / Touboul, C. et al. | 2015
- S20
-
172 Impact of macrophages and age on tumour growth characteristics in a murine ocular tumour modelKilian, M.M. / Pfarrer, C. / Kurts, C. / Holz, F.G. / Löffler, K.U. et al. | 2015
- S23
-
182 Implication of IL-7 in mesothelial paracellular resistance, migration and interaction with colorectal cancer cellsSanders, A. / Owen, S. / Topley, N. / Kift-Morgan, A. / Jiang, W. et al. | 2015
- S24
-
185 Combined proteomics and transcriptomics identifies carboxypeptidase B1 and NF-κB associated proteins as putative biomarkers of metastasis in low grade breast cancerBouchal, P. / Dvořáková, M. / Roumeliotis, T. / Bortlíček, Z. / Ihnatová, I. / Procházková, I. / Ho, J.T.C. / Maryáš, J. / Imrichová, H. / Budinská, E. et al. | 2015
- S25
-
188 Knock down of SOX2, KLF4 and MYC genes increase sensitization to chemotherapeutic drugs and decrease metastasis in prostate cancer stem cellsCastellón, E. / Valenzuela, R. / Cifuentes, F. / Contreras, H. et al. | 2015
- S26
-
191 Potential interactions between Interleukin-20 and Transglutaminase 4 might affect prostate cancer cell functionOwen, S. / Dart, A. / Cui, Y. / Ablin, R. / Mason, M. / Jiang, W.G. et al. | 2015
- S27
-
Translational Research| 2015
- S29
-
208 Different prognostic impact of STK11 mutations in Non-Small-Cell Lung Cancer (NSCLC) illustrates the switch from a tumor suppressor to an oncogenePecuchet, N. / Laurent-Puig, P. / Mansuet-Luppo, A. / Legras, A. / Alifano, M. / Pallier, K. / Didelot, A. / Gibault, L. / Danel, C. / Just, P.A. et al. | 2015
- S30
-
211 Screening for the prevalence of EGFR and ALK mutations in lung adenocarcinoma patients in the levant area, a prospective analysisTfayli, A. / Rafei, H. / Khalil, M. / Mina, A. / Fakhreddin, N. / Mahfouz, R. / Farhat, F. / Rabee, H. / Hamouri, S. / Dbouk, H. et al. | 2015
- S34
-
224 The DETECT study concept - circulating tumor cells (CTCs) in women with advanced breast cancerSchochter, F. / Schramm, A. / Friedl, T.W. / Albrecht, S. / Jäger, B. / Huober, J. / Rack, B. / Trapp, E. / Fasching, P.A. / Taran, F.A. et al. | 2015
- S36
-
229 Hypoxia modulation in Renal Cell Carcinoma by extracellular levels of miR-210 and miR-1233: Implications in time-to-disease progressionDias, F. / Teixeira, A.L. / Ribeiro, B. / Bastos, N. / Fernandes, M. / Sequeira, M.I. / Maurício, J. / Lobo, F. / Klaas, K. / Medeiros, R. et al. | 2015
- S37
-
232 Management of germline findings revealed throughout the course of tumor-normal whole genome sequencing in oncologyLim, H. / Schrader, K. / Young, S. / Fok, A. / Pleasance, E. / Jones, M. / Shen, Y. / Armstrong, L. / Virani, A. / Rassekh, S. et al. | 2015
- S38
-
235 Genomic analyses of circulating tumor DNA in the plasma of neuroblastoma patientsHuetter, S.C. / Walder, D. / Brunner, C. / Ladenstein, R. / Abbasi, M.R. / Ambros, I.M. / Ambros, P.F. et al. | 2015
- S39
-
238 Chromosomal instability in cancer and immune-related genesMadden, S.F. / Collins, D.M. / Gaynor, N. / Gallagher, W.M. / O'Donovan, N. / Crown, J. et al. | 2015
- S41
-
245 Insights on histone deacetylase inhibitors - induced cell death in cancer cell linesSaceda, M. / Castroviejo, N. / Gomez-Martinez, A. / Martinez-Lacaci, I. / Caruana, P. / Ventero, M. / Garcia-Morales, P. et al. | 2015
- S42
-
248 Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patientsPiro, G. / Carbone, C. / Cataldo, I. / Di Nicolantonio, F. / Giacopuzzi, S. / Boschi, F. / Zanotto, M. / Merz, V. / Mina, M.M. / Sbarbati, A. et al. | 2015
- S43
-
252 Intra platelet serotonin and oncological outcomePadickakudy, R. / Haegele, S. / Offensperger, F. / Pereyra, D. / Ohlberger, L. / Assinger, A. / Fleischmann, E. / Brostjan, C. / Gruenberger, T. / Starlinger, P. et al. | 2015
- S44
-
255 Angiogenic effects of low-dose ionizing radiation to peri-tumoral tissueGil Marques, F. / Cardina, C. / Freitas, T. / Mendes de Almeida, J.C. / Pina, F. / Poli, E. / Mareel, M. / Santos, S. Constantino Rosa et al. | 2015
- S45
-
258 Macrocytosis as a potential parameter associated with outcome in the treatment with tyrosine kinase inhibitorsMathijssen, R. / Kloth, J. / Hamberg, P. / Mendelaar, P. / Dulfer, R. / Van der Holt, B. / Wiemer, E. / Kruit, W. / Sleijfer, S. et al. | 2015
- S46
-
261 The insulin-glucose axis in breast cancer - relationship to clinical outcomeGuadagni, F. / Ferroni, P. / Riondino, S. / Laudisi, A. / Portarena, I. / Alessandroni, J. / D'Alessandro, R. / Costarelli, L. / Cavaliere, F. / Buonomo, O. et al. | 2015
- S48
-
267 Molecular profile of 5-fluorouracil pathway genes in colorectal carcinomaKunicka, T. / Prochazka, P. / Krus, I. / Bendova, P. / Protivova, M. / Susova, S. / Hlavac, V. / Liska, V. / Novak, P. / Schneiderova, M. et al. | 2015
- S49
-
270 Differential effects of IGF-1R inhibitors BMS-754807 and OSI-906 in human cancer cell linesSaceda, M. / Poveda-Deltell, M. / Fuentes-Baile, M. / Martinez-Lacaci, I. / Gomez-Martinez, A. / Castroviejo, N. / Encinar-Hidalgo, J.A. / Garcia-Morales, P. et al. | 2015
- S50
-
273 Modelling tumor-stroma crosstalk in vivo by co-implantation of human fibroblasts and human lung cancer cells orthotopically into immuncompromized miceOswald, E. / Espírito Santo, V. / Rudisch, A. / Brito, C. / Sommergruber, W. / Dolznig, H. / Schüler, J. et al. | 2015
- S51
-
276 Delivery of SDF-1α in a matrix-bound manner on cancer cell behaviors: Underlying molecular mechanismsLiu, X. / Dalonneau, F. / Fourel, L. / Sadir, R. / Lortat-Jacob, H. / Albiges-Rizo, C. / Picart, C. et al. | 2015
- S52
-
279 Human liver cancer stem cell resistance to sorafenib and enhanced sensitivity by MK2206 in vitro and in vivoYin, Z. / Zhai, B. / Zhang, X. / Sun, B. / Cao, L. / Zhao, L. / Li, J. / Ge, N. / Chen, L. / Qian, H. et al. | 2015
- S53
-
Early Drug Development| 2015
- S53
-
300 Phase I study of two dosing schedules of the investigational oral pan-RAF kinase inhibitor MLN2480 in patients (pts) with advanced solid tumors or melanomaRasco, D.W. / Middleton, M.R. / Gonzalez, R. / Corrie, P. / Pavlick, A. / Lorigan, P. / Plummer, R. / Gore, M. / Herbert, C. / Agarwala, S.S. et al. | 2015
- S54
-
302 A phase 1 study of EPZ-6438 (E7438), an Enhancer of Zeste-Homolog 2 (EZH2) inhibitor: Preliminary activity in INI1-negative tumorsItaliano, A. / Keilhack, H. / Toulmonde, M. / Coindre, J.M. / Michot, J.M. / Massard, C. / Ottesen, L. / Reyderman, L. / Blakemore, S.J. / Kraljevic, S. et al. | 2015
- S55
-
304 Vanucizumab reduces vessel permeability, perfusion and cellular density of tumor lesions in cancer patients as measured by DCE-MRI and DW-MRINayak, T. / Massard, C. / Martinez Garcia, M. / Le Tourneau, C. / Boni, V. / Garralda, E. / Taus, A. / Albanell, J. / Lahr, A. / Krieter, O. et al. | 2015
- S56
-
307 Population pharmacokinetic and pharmacodynamic modeling of bevacizumab and a proposed biosimilar (GP2019) in healthy male volunteersElmeliegy, M. / Potocka, E. / Renard, D. / Kakar, S. / Skerjanec, A. / Li, Y. / Castro, H. / Izquierdo, M. / Barker, D. et al. | 2015
- S57
-
309 Study of carrier erythrocyte encapsulated fluorouracil in mice with malignant ascitesLuo, F. / Lu, Z. / Wang, G. / Zhang, N. / Yang, J. / Wu, S. / Yang, L. / Jing, X. et al. | 2015
- S58
-
312 A phase I dose escalation study to assess the safety tolerability and pharmacokinetics of ETS2101 in patients (pts) with advanced solid tumoursPlummer, R. / Anthoney, A. / Evans, J. / Haris, N. / D'Archangelo, M. / Slater, S. / Campbell, S. / Brindley, C. / Self, S. / McKeown, P. et al. | 2015
- S59
-
315 Impact of acid-reducing agents (ARAS) on the pharmacokinetics of palbociclib, a weak base with ph-dependent solubility, under differing food intake conditionsSun, W. / Klamerus, K.J. / Yuhas, L.M. / Pawlak, S. / Plotka, A. / O'Gorman, M. / Kosa, M. / Wang, D. et al. | 2015
- S62
-
324 Dose-seeking phase I trials (DSPT) of approved molecularly targeted therapies (MTT): Exhaustiveness and readability of published clinical reportsCousin, S. / Hollebecque, A. / Isambert, N. / Italiano, A. / Kotecki, N. / Postel-Vinay, S. / Gobbo, J. / Toulmonde, M. / Penel, N. et al. | 2015
- S63
-
328 Cancer cell specific and selective photodynamic therapy using newly developed glucose- and oligosaccharide-conjugated chlorinsKataoka, H. / Hayashi, N. / Kubota, E. / Tanaka, M. / Yano, S. / Sakai, Y. / Joh, T. et al. | 2015
- S64
-
331 Safety profile and anti-tumor activity of a new generated human/mouse cross-reactive anti-claudin-4 monoclonal antibody in miceHashimoto, Y. / Kawahigashi, Y. / Hata, T. / Kimura, Y. / Watari, A. / Kondoh, M. / Yagi, K. et al. | 2015
- S67
-
341 Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutationHan, X. / Li, N. / Hu, X. / Song, Y. / Zhang, Y. / Shi, Y. et al. | 2015
- S68
-
344 Single agent supoinoxin targeting phosphorylated p-68 preliminary phase 1 dataGluck, W.L. / Eckhardt, S.G. / Gutierrez, M. / Peterson, C. / Benaim, E. et al. | 2015
- S70
-
350 How effective are novel biological therapies? A systematic review of 121 randomized controlled trials (RCTs)Cho, D. / Roncolato, F. / Man, J.J. / Lord, S.J. / Links, M. / Simes, J. / Lee, C.K. et al. | 2015
- S71
-
353 HIF-2 alpha targeting with a novel RNAi delivery platform as therapy for renal cell carcinomaWong, S. / Cheng, W. / Wakefield, D. / Almeida, A. / Blokhin, A. / Almeida, L. / Hamilton, H. / Subbotin, V. / Hegge, J. / Bertin, S. et al. | 2015
- S72
-
355 Targeting the STAT6 pathway to inhibit tumor-associated macrophages-induced tumor growth and metastasis in breast cancerBinnemars-Postma, K. / Bansal, R. / Storm, G. / Prakash, J. et al. | 2015
- S74
-
362 Phase 1 study of the PSMA-targeted tubulysin small-molecule drug conjugate EC1169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)Ejadi, S. / Vogelzang, N. / Sartor, A. / Clark, R. / Tolcher, A. et al. | 2015
- S75
-
365 Identification of the recommended phase II dose (RP2D) of the c-Met Inhibitor tepotinib (MSC2156119J) in Japanese patients (pts) with solid tumors: A phase I trialYamazaki, K. / Tsushima, T. / Shitara, K. / Sarholz, B. / Fujita, M. / Doi, T. et al. | 2015
- S76
-
367 Effects of alisertib (MLN8237), an investigational Aurora A kinase inhibitor (AAKi), on the QTc interval in patients (pts) with advanced malignanciesZhou, X. / Nemunaitis, J. / Pant, S. / Bauer, T.M. / Patel, M. / Sarantopoulos, J. / Lockhart, A.C. / Goodman, D. / Zhang, B. / Ullmann, C. Dansky et al. | 2015
- S78
-
400 Impact of KRAS/NRAS mutation status on the outcomes of patients with stage III colorectal cancer: Correlative study in NSAS-CC/RCSasaki, Y. / Akasu, T. / Saito, N. / Kojima, H. / Matsuda, K. / Nakamori, S. / Komori, K. / Amagai, K. / Yamaguchi, T. / Nagashima, K. et al. | 2015
- S78
-
Diagnostic/Biomarkers| 2015
- S82
-
413 Accuracy of pleural carcinoembryonic antigen (CEA) assay in malignant pleural effusionsBasso, S.M.M. / Tozzoli, R. / Falcomer, F. / Conte, A. Del / Chiara, G.B. / Lumachi, F. et al. | 2015
- S83
-
416 Variant Alleles in Factor V Leiden (FVL), Prothrombin, Plasminogen Activator Inhibitor-1 (PAI-1) or Methylenetetrahydrofolate Reductase (MTHFR) and risk of thromboembolic events (TEE) in metastatic colorectal cancer (mCRC) patientsFalvella, F.S. / Cremolini, C. / Miceli, R. / Nichetti, F. / Cheli, S. / Antoniotti, C. / Infante, G. / Martinetti, A. / Loupakis, F. / Bartolomeo, M. Di et al. | 2015
- S84
-
419 Androgen receptor (AR) and AR-V7 expression in circulating tumor cells (CTCs) and response to prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in castration-resistant prostate cancer: A correlative analysis from a phase 2 trialPetrylak, D.P. / DiPippo, V.A. / Werner, S.L. / Baird, S. / Anderson, A.K.L. / Marrinucci, D. / Israel, R.J. et al. | 2015
- S85
-
422 Our experience with HER2 screening of the bioptic breast cancer samples using the method fluorescence in situ hybridization in the year 2014 - application of the updated ASCO/CAP guideline recommendationsZmolikova, J. / Pitronova, S. / Uvirova, M. / Kubova, B. / Simova, J. / Strossova, N. / Ziak, D. / Dvorackova, J. et al. | 2015
- S86
-
425 Circulating-free DNA analysis in mouse models of early lung cancerTrigg, R. / Rakhit, C. / Giblett, S. / Kelly, M. / Janus, J. / Martins, M. / Shaw, J. / Pritchard, C. et al. | 2015
- S88
-
431 Biomarkers related to Vanucizumab single agent therapy in serial plasma, tumor tissue and skin wound-healing biopsies of patients with advanced solid tumorsBabitzki, G. / Hidalgo, M. / Massard, C. / Garcia, M. Martinez / Tourneau, C. Le / Boni, V. / Mestres, J. Albanell / Garcia, A. Taus / Alt, M. / Sablin, M.P. et al. | 2015
- S89
-
433 Decrease of pro-angiogenic monocytes predicts clinical response to anti-angiogenic treatment in patients with metastatic renal cell carcinoma (mRCC)Oudard, S. / Benhamouda, N. / Escudier, B. / Ravel, P. / Kothari, D. / Mehmud, F. / Levionnois, E. / Sevin, E. / Negrier, S. / Barthelemy, P. et al. | 2015
- S90
-
436 The Prospective Epidemiologic Risk Factor (PERF I) Study: A novel prognostic serum biomarker reflecting type I collagen degradation is associated with tumor burdenKehlet, S.N. / Bager, C.L. / Willumsen, N. / Dragsb, K. / Neergaard, J.S. / Hansen, H.B. / Bay-Jensen, A.C. / Oersnes-Leeming, D.J. / Christiansen, C. / Karsdal, M.A. et al. | 2015
- S91
-
439 Expression of the mTOR pathway genes as prognostic factors for distance recurrence free survival in breast cancer treated with neoadjuvant therapyAraujo, J. / Flores, C. / Prado, A. / Pinto, J. / Vallejos, C. / Aguilar, A. et al. | 2015
- S92
-
442 VEGFR, CD, MIB-1 and Bcl-2 expressions as long-term prognostic factors in renal cell cancerVirman, J. / Bono, P. / Luukkaala, T. / Sunela, K. / Kellokumpu-Lehtinen, P.L. / Kujala, P. et al. | 2015
- S93
-
445 Clinical utility of chemotherapy based on the estimated primary organ in patients with cancer of unknown primary siteKodaira, M. / Yonemori, K. / Yoshida, A. / Shimoi, T. / Shimomura, A. / Yunokawa, M. / Shimizu, C. / Fujiwara, Y. / Tamura, K. et al. | 2015